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Abstract
Antimicrobial peptides (AMPs) are relatively-short chain molecules that living organ-
isms use to defend themselves against a wide range of invading microorganisms such as
bacteria and viruses. They selectively bind to and kill microbes over host cells by permeabi-
lizing cell membranes or by inhibiting the biological functions of intra-cellular components.
Despite its significance in determining their cell selectivity, however, the cell-concentration
dependence of AMP’s membrane-perturbing activity has not been criticality examined.
In this thesis, we present a physical model for cell selectivity of AMPs, especially its
cell-concentration dependence. To this end, we use a coarse-grained model that captures
essential molecular details such as lipid composition (e.g., fraction of anionic lipids) and
peptide amphiphilicity and charge. In particular, we calculate the surface coverage of pep-
tides in the membrane-perturbing mode as a function of peptide and cell densities: those
that bind to the interface between lipid headgroups and tails. This allows us to extract
the minimum inhibitory concentration (MIC) and the minimum hemolytic concentration
(MHC) of the peptides. Our results show that both MIC and MHC increase as the cell den-
sity increases so that the peptide selectivity (given by MHC/MIC) decreases with increasing
cell density. Our results will help resolve conflicting interpretations of peptide-selectivity
experiments.
iii
Acknowledgements
I would like to express my sincere gratitude to my supervisor, Dr. Bae-Yeun Ha, for
the useful comments, remarks and engagement through the learning process of this thesis.
I am grateful to my defence and advisory committee members, Dr. Russell Thompson,
Dr. Zoya Leonenko, and Dr. Mohammad Kohandel, for their constructive comments and
suggestions that I found useful in improving this work. I am also thankful to Sattar Taheri-
Araghi and Zheng Ma, the senior members of our research group. Their constructive pieces
of advice and cooperation helped me a lot to progress in my research projects.
I am particularly thankful to my parents for everything I have earned in my life. Their
unconditional love and support have always encouraged me to pursue my dreams and never
give up. My sisters deserve my wholehearted thanks as well.
My special thanks go to my amazing friends Kier von Konigslow and Rabab Mashayekhi
for all their support and encouragement in my many, many moments of crisis.
iv
This thesis is dedicated to my parents
for all they did.
v
Table of Contents
List of Figures viii
1 Introduction 1
1.1 Motivation and goals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Antimicrobial peptides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.2.1 Mechanism of action . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.3 Cell membrane and lipid bilayer . . . . . . . . . . . . . . . . . . . . . . . . 8
1.4 Bacteria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
1.5 Overview of the thesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2 Electrostatics for electrolyte solutions 12
2.1 Poisson-Boltzmann theory . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
2.2 The linearised PB equation: Debye-Huckel theory . . . . . . . . . . . . . . 14
2.3 The Poisson-Boltzmann equation in planar geometry . . . . . . . . . . . . 15
3 Effect of cell concentration in activity and selectivity of antimicrobial
peptides 20
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
3.2 Molecular model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
3.3 Free energy calculation and Wigner-Seitz Cell approximation . . . . . . . . 25
3.3.1 Lipid demixing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
vi
3.3.2 Random coil peptides in ionic solutions . . . . . . . . . . . . . . . . 33
3.3.3 Total free energy of the peptide-membrane system . . . . . . . . . . 36
3.4 Results and Discussions . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
3.4.1 Binding isotherms . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
3.4.2 Asymmetric binding of peptides . . . . . . . . . . . . . . . . . . . . 46
3.4.3 Peptide selectivity: therapeutic index . . . . . . . . . . . . . . . . . 48
3.4.4 Lipid packing shape and threshold surface coverage . . . . . . . . . 49
3.5 Summary and Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
APPENDICES 62
A Entropy of the salt ions interacting with a charged surface in a (1:1)
electrolyte solution 63
B Langmuir binding model 65
C The MATLAB Code used in the project 67
C.1 The function to calculate the free energy of the peptide-membrane system 74
C.2 The function to calculate the WSC free energy . . . . . . . . . . . . . . . . 77
References 80
vii
List of Figures
1.1 Illustration of different types of pores induced by α-helical peptides (adapted
from Ref. [1]) The hydrophilic side of the helical peptide is shown in blue
and the hydrophobic side in orange. (a) In toroidal pores, the hydrophilic
side of the peptide faces the lipid bilayer and the hydrophobic side faces
water. (b) In barrel-stave pores, the hydrophobic side of the peptide faces
the lipid bilayer and the hydrophilic side is exposed to water. (c) In the
carpet model, the membrane is covered extensively by the peptides and
eventually micelles are created. . . . . . . . . . . . . . . . . . . . . . . . . 7
1.2 Illustration of the different self-assembly structures of lipids. Once there is
enough lipids in solution, they self assemble in a shape-dependent manner:
(a) The so-called cylindrical lipids, such as PC, form bilayer, (b) inverted-
cone shaped lipids like lysolipids tend to form micelles, (c) cone-shaped lipids
like PE form inverted micelles. . . . . . . . . . . . . . . . . . . . . . . . . 8
1.3 Schematic view of the membrane structure of Gram-positive and Gram-
negative bacteria. In both cases, there is a cytoplasmic membrane (inner
membrane), which is composed of phospholipids. However, Gram-negative
bacteria have an outer membrane as well, which its inner leaflet is made of
phospholipids, while the outer leaflet is made of a different type of lipids
known as lipopolysaccharides. . . . . . . . . . . . . . . . . . . . . . . . . . 10
2.1 Charged membrane with negative surface charge density in a salty solution.
The planar membrane is infinitely extended in the (x, y) plane where its
orthogonal cross section normal to the y axis is illustrated here. Due to
the presence of the charged membrane a density profile of n±(z) is created
for cations and anions. In the vicinity of the membrane, the density of the
counterions is increased while the density of the co-ions (like-charged ions)
is decreased. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
viii
3.1 Illustration of peptides in different binding modes on the lipid bilayer. Pep-
tides in binding mode I are inserted into the interface between lipid head
group and tails. Peptides in binding mode S are electrically bound to the
surface. In symmetric binding, peptides are evenly distributed between the
inner and outer monolayers. . . . . . . . . . . . . . . . . . . . . . . . . . . 24
3.2 Illustration of peptides hexagonal lattice on the surface (top view) . . . . . 27
3.3 Illustration of peptide binding modes on the membrane (side view): (A)
membrane inserted (binding mode I), (B) surface adsorbed (binding mode S). 28
3.4 Schematic view of zone 1 and zone 2 of the WSC in the semi-analytical cal-
culations. (A) The peptide at the center of the WS cell is interfacially bound
to the membrane (binding mode I). (B) The bound peptide is adsorbed onto
the surface (binding mode S). There are less number of lipids in Zone 1 for
a peptide in the binding mode I compare to that of in the binding mode S. 30
3.5 The molar ratio of membrane-embedded peptides (in binding mode I) P/L,
a good measure of membrane perturbing activity of AMPs, as a function
of concentration of peptides in bulk Cp for peptide charge Q = 6. Higher
binding of peptides on the bacterial membrane with α¯ = 0.3 compare to
that of the host cell with α¯ = 0.05 is seen in this figure, which reflects the
selective antimicrobial activity of the peptide. . . . . . . . . . . . . . . . . 42
3.6 The molar ratio of the membrane-disrupting peptides (in binding mode I)
to lipids P/L as a function of peptide concentration in bulk Cp, for α¯ = 0.3
(typical for a bacterial membrane), peptide charge Q = 6 and various bacte-
rial cell densities Cb as specified in the figure. By increasing the cell density,
binding starts at a higher peptide concentration. The binding isotherm of
the single target case (one cell in the solution) is also included for compari-
son. For any cell density, at very high peptide concentration when Cp  Cb,
binding follows the behaviour of the single target case. . . . . . . . . . . . 43
3.7 P/L as a function of peptide concentration in bulk Cp, for the host cell
membrane α¯ = 0.05, peptide charge Q = 6 and various host cell densities
Ch as specified in the figure. Similar to the bacterial membrane case: by
increasing the cell density, binding starts at a higher peptide concentration.
The binding isotherm of the single target case (one host cell in the solution)
is also included. For the first three choices of the cell density, binding is
similar to the single target cell (plots lie on top of each other). Nevertheless,
binding isotherms of all the cell concentrations, in general, converge to that
of the single cell case at high concentrations of peptides. . . . . . . . . . . 44
ix
3.8 P/L as a function of cell density for the bacterial case (α¯ = 0.3) and a
few choices of bulk peptide concentration Cp. For a fixed Cp, binding is
constant at very low cell densities, it then decreases by increasing the cell
density and goes to zero for very large densities of bacterial cells. However,
the cell concentration at which binding is diminished is higher for a larger
value of Cp. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
3.9 P/L as a function of bulk concentration of peptides Cp, for peptide charge
Q = 6, α¯ = 0.3 and Ct = 5× 105 cells/mL. In the symmetric binding, there
are less number of peptides to lipids on the outer layer, compared to the
asymmetric case. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
3.10 (a) Extraction of MIC for peptide charge Q = 6 and various densities of
bacteria. (b) Extraction of MHC for various densities of host cells and
peptide charge Q = 6. In both cases, we have used the experimental data
for P/L∗. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
3.11 (a) MHC as a function of cell density for peptide charge Q = 6 and two
choices of cell area as specified in the figure. (b) MIC as a function of cell
density for Q = 6 and target membrane area AB = 12× 10−12. . . . . . . . 54
3.12 MHC/MIC, a good measure of peptide selectivity, as a function of cell con-
centration for peptide charge Q = 6 and two different choices of host cell
area AH as determined in the figures. (a) Both host cells and bacteria have
the same cell densities. (b) Host cells have a fixed cell density NH while bac-
terial density is varying. Regardless of the choice of cell densities, peptide
selectivity is higher for a larger host cell area. . . . . . . . . . . . . . . . . 55
3.13 Cell concentration dependence of peptide selectivity within the Langmuir
binding model: (a) MHC as a function of cell density for different choices of
peptide threshold concentration P/L∗ as specified in the figure. (b) MIC as
a function of cell density for the two different values of P/L∗. (c) MHC/MIC
as a function of cell density for different choices of P/L∗ on the membranes
as specified in the figure. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
3.14 P/L as a function of Cp for two different targets: microbe (w = −25.32),
and host cell (w = −19). Peptide binding on two targets is compared for
a few choices of cell densities Ct. The gap between the curves δ does not
change by increasing the cell density. . . . . . . . . . . . . . . . . . . . . . 59
3.15 (a) Zoom-in plot of Fig. 3.14a for cell density Ct = 6 × 102 cells/mL. (b)
Zoom-in plot of Fig. 3.14e for cell density Ct = 6× 106 cells/mL. Regardless
of the cell density the gap between the two curves is of the order of 10−5µM 60
x
3.16 MHC/MIC as a function of cell density from two different models: the full
analysis based on electrostatic interactions and the Langmuir binding model. 61
xi
Chapter 1
Introduction
1.1 Motivation and goals
During the last couple of decades, there has been a noticeable rise in bacterial resistance.
As a result, many antibiotics have become ineffective against an increasing number of
pathogenic microbes. Accordingly, much effort has been made to develop new antimicrobial
therapeutics. Antimicrobial peptides (AMPs) or their analogues have been considered as
promising candidates among others [2].
AMPs are key components of the innate immune system of almost all living organisms
from prokaryotes to humans [3]. While AMPs have constantly provided a first-line of de-
fence for the organisms against microbes and other invading pathogens, microbes have not
easily adapted to evade their lethal mechanism of action. In other words, AMP’s mech-
anism of action does not easily induce microbial resistance. Furthermore, these peptides
have a broad-spectrum antimicrobial activity. They have been shown to be active against
a wide range of bacteria, fungi, yeast, viruses, and even tumor cells. As a result, AMPs
are believed to have a great potential to solve the bacterial resistance problem, as they
present a novel class of antibiotics.
The antimicrobial or host defence peptides have stimulated considerable research not
only to understand the biology of the innate immune system, but also to design new
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therapeutic compounds [2, 4]. To date, a few AMPs, such as Pexiganan a magainin 2
analogue, have advanced to clinical trials [2]. The trials are, however, generally focused on
the topical application of these peptide therapeutics, because their cytotoxicity prevents
their direct injection into the bloodstream.
The main obstacle to the development of AMPs as therapeutics with systemic appli-
cations is that many natural AMPs are not highly selective between microbial and host
cells. For instance, well-studied peptides such as magainins, in spite of being active in
vitro, showed weak antimicrobial activity in animal models of infection [2]. As sufficiently
high doses needed to effectively kill the invading pathogens, they may kill the host cells.
“Good” AMPs should be both active (killing the microbes effectively) and selective (being
able to discriminate host cells).
Along this line, there have been many attempts to optimize the activity and selectivity
of AMPs by tuning their physiochemical properties such as peptide charge and hydropho-
bicity [5, 6, 7]. A comprehensive review can be found in Ref. [8]. Taheri-Araghi and Ha,
using a coarse-grained model of peptide-lipid systems, showed that antimicrobial activity
and selectivity of AMPs is optimized at a peptide charge Qˆ & 4 in a salt-concentration
dependent manner: the higher the salt concentration, the larger the Qˆ [9]. As pointed out
recently [8], however, it is not clear how cell concentrations are implicated in the selectivity.
Despite its significance, the cell selectivity has not been critically examined. In particu-
lar, how cell concentrations are implicated in the selectivity remains to be clarified. In this
thesis, we propose a physical model for cell selectivity of AMPs, which enables us to exam-
ine its dependence on cell concentrations. Obviously, partitioning of peptides among target
cells depends on the cell concentration, since different cells compete to recruit peptides. As
detailed in this thesis, this suggests that the activity and selectivity of AMPs diminishes
as the cell concentration increases. An important lesson of our studies presented here is
that cell selectivity analysis needs to be done with caution – with appropriate choices of
host and microbial cell concentrations.
2
1.2 Antimicrobial peptides
AMPs are ubiquitously found in nature. All living organisms including animals, plants,
humans and bacteria use AMPs as part of their innate immunity to protect themselves
against the invading pathogenic microbes [10]. These gene encoded molecules are similar
to proteins in structure, however they are shorter in size (< 100 amino acids) and are
thus, so to speak, short proteins. The structural diversity among AMPs is so huge that
it is not easy to classify them based on their amino acid sequence. So far, more than
800 AMPs have been discovered, each with a different sequence [2]. Nevertheless, AMPs
are classified into four main classes based on the conformation they adopt upon binding
to lipid membranes: α-helical, β-sheet, loop, and extended peptides [11]. The first two
classes are the most abundant in nature. Examples include helical magainin and β- sheets of
tachyplesins isolated from the skin of the African clawed frog Xenopus laevis and horseshoe
crab hemolymph, respectively [12].
The physiochemical properties of proteins and peptides are related to the sequence
of the amino acids in their structure [13]. There are 20 standard amino acids in nature
with different characteristics, as listed in Table 1.1 (adapted from Ref [14]). Despite a
large sequence diversity, AMPs share some common characteristics such as a net positive
charge and amphiphilicity [8] . Their positive charge is due to the presence of several basic
residues in their structure such as lysine and arginine [10]. The cationic charge of AMPs is
known to be responsible for their cell selectivity toward microbes, because the membranes
of bacteria are more negatively charged than that of host cells.
AMPs have a distinct amphiphilic structure [10], that is, their sequence contains both
hydrophilic (polar) and hydrophobic (nonpolar) residues, located on opposite sides of the
molecule. The amphiphilicity of peptides enables them to interact effectively with lipid
membranes as they also have an amphiphilic structure. Indeed, hydrophobic interaction
between the hydrophobic face of the peptides and the hydrophobic core of the lipid mem-
brane is the dominant interaction between peptides and host cells [8]. In other words,
hydrophobicity of AMPs is one of the key parameters to control their cytotoxicity. Melit-
tin, discovered in bee venome, is more toxic to mamalian cells compared to magainin,
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Table 1.1: Amino acids and their physiochemical properties
Amino acid 3-letter name side-chain polarity net charge
Alanine Ala nonpolar 0
Arginine Arg polar +1
Asparagine Asn polar 0
Aspartic acid Asp polar -1
Cysteine Cys nonpolar 0
Glutamic acid Glu polar -1
Glutamine Gln polar 0
Glycine Gly nonpolar 0
Histidine His polar 0
Isoleucine Ile nonpolar 0
Leucine Leu nonpolar 0
Lysine Lys polar +1
Methionine Met nonpolar 0
Phenylalanine Phe nonpolar 0
Proline Pro nonpolar 0
Serine Ser polar 0
Threonine Thr polar 0
Tryptophan Trp nonpolar 0
Tyrosine Tyr polar 0
Valine Val nonpolar 0
which is believed to be due to its higher hydrophobicity. Several studies have also revealed
that reducing peptides hydrophobicity reduces their hemolytic activity [8, 15, 16].
1.2.1 Mechanism of action
In general, AMPs are known as bacteriocidal agents that kill the microbes as oppose to
bacteristatics, which just stop the growth of bacteria [10, 17]. Their cell-killing activity
is fast; some peptides such as magainin 2 and cecropin PI have been shown to kill the
bacteria in 15-90 minutes [17].
Despite extensive studies on AMPs, their exact microbial killing mechanism is not yet
clearly understood. However, it is known that they are pore formers that target the cyto-
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plasmic membrane of bacteria [10, 18]. Examples include magainin2, melittin, cecropin and
alamethicin. As discussed in reference [17], there are three main steps involved in bacterial
killing mechanism of AMPs: (i) attraction, (ii) attachment, (iii) membrane permeability.
Attraction
Peptides should be attracted to bacteria in order to kill them. In fact, this step is related
to one of the most significant features of antimicrobial activity of AMPs, known as cell
selectivity, the ability to recognize the bacteria in a crowd of host cells [10]. The under-
lying mechanism is electrostatic attraction between the peptides and the cell membranes
[17]. Peptides are typically positively charged. In contrast, the outer leaflet of the outer
membrane of bacteria is abundant in anionic lipids while host cells are almost neutral on
their outer layers [10]. Thus strong electrostatic attractions between the cationic peptides
and negatively charged bacterial membranes enables them to recognize bacteria as their
main target [19].
Attachment
Electrostatic interactions bring AMPs into close proximity of lipid bilayers. The distinct
amphiphilic structure of peptides then facilitates their hydrophobic binding to the cell
membrane [17]. They attach to the membrane to establish the hydrophobic interaction
between their hydrophobic side and the hydrophobic tails of lipids. According to the
thorough experiments of Huang et al. on interaction of AMPs with model membranes, there
are two binding modes for peptides on the membrane [20]. Their oriented circular dichroism
(OCD) studies showed that, at low peptide to lipid ratios P/L, peptides lie parallel to the
plane of the membrane [21]. They are indeed embedded in the interface between the
lipid headgroups and tails, and stretch the membrane as was observed in the membrane
thickness measurements [22]. They observed that membrane thickness reduces as the
concentration of the peptides increases [23]. Since the volume of the hydrophobic core of
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the membrane (lipid chains) is conserved, membrane thinning happens as a consequence of
its area stretch. Nevertheless, membrane thickness remains constant above some threshold
concentration of peptides P/L∗, which implies a different type of peptide-lipid interaction.
Furthermore, orientation of bound peptides changes above this threshold concentration,
and they are inserted perpendicular to the membrane (second binding mode)[22]. This
peptide reorientation is concomitant with the formation of transmembrane pores [22].
Membrane permeability
As the concentration of bound peptides increases, the peptide-induced stress in the mem-
brane also increases. Above the threshold P/L∗ the membrane is disrupted to relieve the
built-up tension. Although the exact membrane permeability activity of peptides is not
yet clear, some models have been proposed to explain how they disturb the membrane. In
what follows, we briefly discuss the models.
As summarized in reference [17], AMPs either form pores in the membrane or de-
teriorate the integrity of the membrane by micellization in a detergent-like way. Both
mechanisms eventually lead to cell death. Pore former peptides rupture the cell membrane
via two different types of pore: toroidal pores and barrel-stave pores [24]. Figure 1.1 shows
the different types membrane-disruption mediated by AMPs.
In toroidal pores, peptides are inserted perpendicularly into the membrane and induce
the lipid monolayers to bend continuously in such a way that the pore lumen is partly lined
by peptides and partly by lipid head groups [25]. In this type of pores, as seen in Fig. 1.1 the
charged (hydrophilic) side of the peptide faces the bilayer and lipid headgroups. Toroidal
pores are highly curved structures that are stabilized due to the presence of peptides in
the pore [26]. Magainin is one of the AMPs that forms toroidal pores in the lipid bilayer.
Magainin pores are large and each pore includes 4-7 magainins [17].
In contrast, there exists the barrel-stave pores, which are uniquely formed by the antimi-
crobial peptide alamethicin [17, 25]. These peptides align perpendicular to the membrane
and associate to form a bundle (much like a barrel of peptides), which is oriented parallel
6
(a)
(b)
(c)
Figure 1.1: Illustration of different types of pores induced by α-helical peptides (adapted
from Ref. [1]) The hydrophilic side of the helical peptide is shown in blue and the hy-
drophobic side in orange. (a) In toroidal pores, the hydrophilic side of the peptide faces
the lipid bilayer and the hydrophobic side faces water. (b) In barrel-stave pores, the hy-
drophobic side of the peptide faces the lipid bilayer and the hydrophilic side is exposed to
water. (c) In the carpet model, the membrane is covered extensively by the peptides and
eventually micelles are created.
to the phospholipid tails. This transmembrane pore is lined by peptides only and, unlike
the toroidal pores, the hydrophilic regions of the peptides form the edges of the pore.
Barrel-stave pores are smaller than toroidal pores. The number of peptides in the pores is
estimated to be 3-11, depending on the bilayer lipid composition [17].
There is another AMP-induced membrane disruption mechanism called carpet model
[18]. In this model, peptides tend to reside parallel to the plane of the membrane. They
largely cover the surface of the membrane in a carpet-like manner. At high concentration
of peptides, they disintegrate the membrane and eventually form micelles similar to the
effect of detergents. Ovispirin is an AMP that uses this mechanism of action [17].
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(a) (b) (c)
Figure 1.2: Illustration of the different self-assembly structures of lipids. Once there is
enough lipids in solution, they self assemble in a shape-dependent manner: (a) The so-
called cylindrical lipids, such as PC, form bilayer, (b) inverted-cone shaped lipids like
lysolipids tend to form micelles, (c) cone-shaped lipids like PE form inverted micelles.
1.3 Cell membrane and lipid bilayer
Cells are the fundamental units of life. They are microscopically categorized into two
groups: prokaryotic and eukaryotic [13]. Bacteria are the best representatives of the first
group. The second group, eukaryotes, includes all the cells in animals, plants and fungi.
Prokaryotic cells are generally smaller than eukaryotes. In both types of cell there is a
membrane (cytoplasmic membrane) that encapsulates the cytoplasm and other intracellu-
lar components [27]. The membrane is mainly made of a lipid bilayer [13].
Lipids are amphiphilic molecules that consist of hydrophilic (polar) and hydrophobic
(nonpolar) components, usually referred to as lipid head group and lipid tails, respectively.
In aqueous solutions, they self-assemble into structures where the hydrophilic parts shield
the hydrophobic parts from water molecules. The preferred structure is determined by
size, shape, and the concentration of lipids [27]. As depicted in Fig. 1.2, it can be a lipid
bilayer, a micelle, or an inverted micelle. The most abundant lipids in all cell membranes
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are phospholipids. They have two fatty acid tails and also all of them have a phosphate
group in their headgroups. A schematic view of phospholipid molecules can be seen in
Fig. 1.2.
It is worth noting that the lipid curvature, which will be discussed in the third chapter,
is in fact related to the curvature of its preferred self-assembly. Lipids that tend to form
lipid bilayers are known to have a zero curvature. Positively and negatively curved lipids
prefer the micelle and the inverted micelle structures, respectively.
1.4 Bacteria
Bacteria along with eukaryotes and archae constitute the three major forms of life. They
are prokaryotic cells. Due to their small size, which is on the order of micrometers (µm),
they are often referred to as microorganisms. Based on their shapes, bacteria are divided
into three major groups: rods, spheres, and spirals.
As discussed previously, both bacteria and eukaryotes have a so-called cytoplasmic
membrane (lipid bilayer) that surrounds the cell. In eukaryotes, it is only this lipid bilayer
that separates the inside of the cell from the outside. However, in case of bacteria, there
is a cell wall on top the lipid membrane as well, which mainly acts as protection for the
cell. There are two major types of cell walls; based on the cell walls, bacteria are classified
into two groups: Gram-positive and Gram-negative [13]. A schematic view of different cell
walls is shown in Fig. 1.3. The so-called gram-staining property of bacteria is, in practice,
determined by their response to some test dyes.
For Gram-positive bacteria, the cell wall contains a thick layer of peptidoglycan, a
copolymer made of amino acids and sugars. Due to this peptidoglycan layer, they can
retain the violet dye used in gram-staining tests, and are thus called gram-positive.
The cell walls of gram-negative bacteria are made of an outer membrane as well as
a peptidoglycan layer. In other words, these bacteria have two membranes: the inner
membrane (cytoplasmic membrane) and the outer membrane (see Fig. 1.3). There is a
layer of peptidoglycan in between the two membranes which is thinner than that of the
9
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Figure 1.3: Schematic view of the membrane structure of Gram-positive and Gram-negative
bacteria. In both cases, there is a cytoplasmic membrane (inner membrane), which is
composed of phospholipids. However, Gram-negative bacteria have an outer membrane as
well, which its inner leaflet is made of phospholipids, while the outer leaflet is made of a
different type of lipids known as lipopolysaccharides.
gram-positive bacteria. Thus, they fail to retain the dye in the gram-staining procedure,
and are called gram-negative. The inner membrane is the plasma lipid membrane, mostly
made of phospholipids. The outer membrane has a somewhat different structure; the inner
leaflet is made of phospholipids, and the outer leaflet is comprised of another type of lipid
called lipopolysaccharide (LPS)[28].
Note that the main target of AMPs, in their microbe killing mechanisms, is the cyto-
plasmic membrane of bacteria. Thus, in the case of gram-positive bacteria, AMPs should
pass across the peptidoglycan layer to reach the membrane. For gram-negative bacteria,
however, they should pass across the outer membrane as well as the peptidoglycan layer
before they can interact with the cytoplasmic membrane.
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1.5 Overview of the thesis
The first chapter of this thesis is an introduction of the motivation and goals of this work.
It is then followed by a brief overview of antimicrobial peptides (AMPs), their mechanism
of action, structure of cell membranes, and bacteria.
In the second chapter, we describe the electrostatics for electrolyte solutions. The ana-
lytical tools to study the electrostatic interaction of such solutions, the Poisson-Botzmann
equation and its linearized form the Debye-Huckel equation, are discussed in this chapter.
The third chapter is dedicated to the coarse-grained semi-analytical model we devel-
oped to consider the implication of cell concentration in activity and selectivity of AMPs.
More specifically, using the Poisson-Boltzmann theory for charged surfaces, we study the
interaction of peptides with a demixable lipid membrane. We will discuss how considering
more than one lipid membrane, equivalent to considering a density of target cells, affects
the selective membrane-disruptive activity of AMPs. We then developed a single-binding
site approach to simulate peptide-membrane interactions. In this model, peptide bind-
ing is driven by a fixed binding energy and there is no interaction between the bound
peptides on the membrane. In the end, we compare the results of this model with the
results of the coarse-graining. Since the coarse-grained approach is mainly based on elec-
trostatic interactions, the comparison indicates the effect of electrostatic interactions in
the cell-concentration dependence of peptide activity and selectivity.
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Chapter 2
Electrostatics for electrolyte solutions
2.1 Poisson-Boltzmann theory
Electrostatic interactions play important roles in determining the structure and function of
biological systems in aqueous solution. For instance, the presence of multivalent counteri-
ons can induce condensation of negatively charged DNA molecules into ordered structures
[29]. In addition, electrostatic interactions often control molecular association between
charged objects. For instance, cationic antimicrobial peptides preferentially bind to mem-
branes carrying anionic lipids such as bacterial cell membranes [12]. The potency of these
peptides as therapeutic agents relies on this selectivity, as detailed in the next chapter.
In this chapter, we present Poisson-Boltzmann (PB) theory, a standard mean field ap-
proach to charged systems in an electrolyte solution. Here, our consideration is limited to
the simple case of a uniformly-charged surface interacting with mobile ions. Such a consid-
eration will be useful for developing an adequate theoretical approach to more complicated
systems introduced in the next chapter.
Any substance that dissolves into ions in a polar solvent like water is called an electrolyte
and the resulting ionic solution is called the electrolyte solution [30]. The electrostatic
interactions among charged molecules in an electrolyte solution are not solely determined
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by their direct Coulomb forces but are screened by the surrounding dissolved ions. An
anionic molecule, for instance, tends to be surrounded by cationic ions (e.g., Na+). The
anionic charge is thus “shielded” by an ionic cloud of opposite charge, forming the so-called
diffusive layer. As a result, the electric potential due to the anionic charge is screened and
weakened.
The equilibrium distribution of ions in solution is determined by the balance between
energy and entropy. In statistical mechanics, the distribution of the ions is obtained using
the Poisson-Boltzmann (PB) equation captures this at the mean-field level. It is a dif-
ferential equation that determines simultaneously the charge density and the electrostatic
potential at the same point inside the solution. It is basically derived from the Poisson
equation combined with the Boltzmann distribution function.
In electrostatics, the relation between the electric potential ψ(r) and the charge distri-
bution is given by the Poisson equation
∇2ψ(r) = −ρ(r)
0w
=
−e
0w
∑
i
zini (2.1)
where ρ(r) is the total charge density at r, 0 the electric permittivity of vacuum and w
the dielectric constant of the aqueous solution. The second equation describes the total
charge density in an electrolyte solution containing different ion species denoted by i. Each
ion has a number density of ni(r) and a charge of number −ezi with −e the electrostatic
charge and zi the charge (valence) number.
In statistical thermodynamics, ions in electrolyte solution are assumed to obey Boltz-
mann statistics. Thus, the density of ions at position r is related to the probability of
finding them at r which is given by Boltzmann factor.
ni(r) = n
0
i exp(−eziψ(r)/kBT ) (2.2)
Where n0i is the density of ion i at infinity (limr→∞ ψ(r) = 0). The exponential argument
indeed gives the electrostatic energy of the ith ion at r, with kB the Boltzmann constant
and T the temperature.
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By substituting ion distributions from Eq. 2.2 into the Poisson equation Eq. 2.1 we
obtain the well known Poisson-Boltzmann equation.
∇2ψ(r) = −e
0w
∑
i
zin
0
i exp(−eziψ(r)/kBT ) (2.3)
We can assume for simplicity that there is just one type of counterion with number density
of n+0 and valence z+ and one type of co-ion with n
−
0 and z−. For such ionic solution the
PB equation is reduced to
∇2ψ(r) = −e
0w
(
z+n
+
0 exp(−ez+ψ(r)/kBT + z−n−0 exp(−ez−ψ(r)/kBT
)
(2.4)
In a 1:1 electrolyte solution such as NaCl, which is also the case in this thesis, we have
n+0 = n
−
0 = n0 and z− = −z+ = −1. Eq, 2.4 is then further simplified as
∇2φ(r) = κ2 sinh[φ(r)] (2.5)
Where φ = eψ/kBT is the reduced electrostatic potential and κ is the inverse of Debye
screening length defined as κ2 = ( 1
λD
)2 = 8pie2n0/4pi0wkBT . It is more common to write
κ2 = 8pilBn0 with lB the Bjeruum length defined as, lB = e
2/4pi0wkBT . In fact, the
Bjeruum length is the separation between two elementary charges in an ionic solution with
dielectric constant w at which their electrostatic interaction is comparable to the thermal
energy.
2.2 The linearised PB equation: Debye-Huckel theory
When the charged bodies inside the solution are weakly charged (eψ(r) kBT ) we can use
Taylor expansion to expand the PB equation Eq. 2.5 to the first order of φ i.e., sinh(φ) ≈ φ.
The resulting linearised form of the PB equation is known as the Debye-Huckel equation
∇2φ(r) = κ2 φ(r) (2.6)
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Here, φ(r) = eψ/kBT is the reduced potential, however, needless to say that the same
equation holds for the electric potential ψ(r) as well. This linear second order differential
equation is analytically solvable for different geometries. Let us consider the simple scenario
of an infinitely extended planar membrane with uniform surface charge density σ which
is depicted in Fig. 2.1. Due to the symmetric configuration of the membrane in the (x,
y) plane, the electric potential is just a function of z. Requiring zero potential at far
distances from the membrane (limr→∞ ψ(r) = 0), and a constant electric field on the
surface ∇ψ(0) = −σ/0w, the solution of the Eq. 2.6 is
ψ(z) =
σ
0wκ
exp(−κz). (2.7)
The effect of salt ions in the potential is seen through κ. Electrostatic potential is
exponentially decreasing due to the screening effect of the salt ions in the ionic solution.
As seen in Eq. 2.7, electrostatic interactions are effectively suppressed beyond the Debye
screening length (when κz > 1). The screening length is related to the salt concentration,
κ−1 = (8pilBn0)−1/2. It varies from around 3 A˚ for 1 M of a (1:1) electrolyte (e.g., NaCl)
to about 1 µm for pure water (with H+ and OH− ions).
2.3 The Poisson-Boltzmann equation in planar geom-
etry
The Debye-Huckel theory is valid for low potential surfaces (smaller than 25 mV at room
temperature), but for highly charged surfaces the original PB equation (see Eq. 2.5) is
better suited than the DH theory. In general, the PB equation is a nonlinear equation
which is numerically solvable for different boundary conditions. It can, however, be solved
analytically for a planar geometry. As discussed in Ref. [31], the PB potential on the surface
of a planar membrane with surface charge density σ is given as
φ0 = 2 sinh
−1
(
2 piσlB
κ
)
(2.8)
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Zbackbone
 charges
co-ions
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Figure 2.1: Charged membrane with negative surface charge density in a salty solution. The
planar membrane is infinitely extended in the (x, y) plane where its orthogonal cross section
normal to the y axis is illustrated here. Due to the presence of the charged membrane a
density profile of n±(z) is created for cations and anions. In the vicinity of the membrane,
the density of the counterions is increased while the density of the co-ions (like-charged
ions) is decreased.
where φ0 = eψ0/kBT is the reduced surface potential.
The advantage of having the surface potential is that we can now calculate the electro-
static free energy of the membrane F , using the so-called Debye charging process: in this
method, the free energy is given by the work that is done to charge up the membrane from
0 to its final surface charge density σ
F = A
∫ σ
0
ψ0(σ
′) dσ′ (2.9)
where ψ0 is the surface potential and A the area of the membrane. Using the surface
potential given in Eq. 2.8, the charging free energy per unit area of the planar membrane
is obtained as
Fe(σ) = σ φ0 − κ
pi lB
[
cosh
(
φ0
2
)
− 1
]
(2.10)
where Fe describes the total electrostatic free energy of a membrane which carries a surface
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charge density σ and is immersed in an ionic solution with screening length κ. Eq. 2.10
is one of the key equations throughout this thesis; in fact, it will be used to compute the
free energy of the membrane in our modelling . It is worth noting that entropy of the salt
ions and their contribution to the electrostatic energy is also incorporated in Fe. In other
words, calculation of the free energy using Debye charging method (Eq. 2.9) is equivalent
to the direct calculation of the membrane-solution system as
F =
0w
2
∫
[∇ψ(r)]2dr + kBT
∫ [
n+ ln
n+
n0
+ n− ln
n−
n0
− (n+ + n− − 2n0)
]
dr (2.11)
Here, the first term gives the total electrostatic energy of the membrane-solution system
with ψ(r) the electric potential at r. The second term describes the entropy of the salt
ions. In this term, n+ (n−) is density of the cationic (anionic) ions and n0 density of the
salt ions far from the membrane at z = +∞ (ψ = 0 at z = +∞).
Equality of the two different methods to calculate the free energy given in Eq. (2.9)
and Eq. (2.11) can be easily shown using the DH theory. To do so, we consider a planar
membrane with low surface charge density similar to the one we already discussed in section
2.2, and calculate its free energy using DH theory in two alternative ways.
Let us first consider the Debye charging method. The DH potential for the planar
membrane in a salt solution is given in Eq. 2.7. The surface potential then reads ψ0(z =
0) = σ/(0wκ). Substituting the surface potential into the charging free energy in Eq. 2.9
we have
FDC
A
=
∫ σ
0
σ
0wκ
dσ =
σ2
20wκ
(2.12)
where FDC is the electrostatic charging free energy per unit area of the membrane.
Let us now compute the free energy of the planar membrane using the alternative
method given in Eq. 2.11; the two terms in the free energy (the electrostatic energy and
the entropy of the salt ions) are calculated separately. Using the DH potential for the
planar geometry in Eq. 2.7, the electrostatic energy of the system is given as
0w
2
∫
[∇ψ(r)]2dr = 0w
2
A
∫ ∞
0
[− σ
0w
exp(−κz)]2dz = Aσ2
40wκ
(2.13)
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To calculate the entropy of the salt ions, we need to know their spatial distribution
(density as a function of position r). As discussed in Sec. 2.1, the density of the cations
and anions is related to their Boltzmann weight
n±(z) = n0 exp(∓eψ(z)/kBT ) (2.14)
where ψ(z) is the electric potential; here we use the DH potential in Eq. 2.7. Using
their number densities n±(z), the entropy of the salt ions is calculated as (the details of
the calculation is found in appendix A)∫ [
n+ ln
n+
n0
+ n− ln
n−
n0
− (n+ + n− − 2n0)
]
dr =
Aσ2
40wκ
(2.15)
The electrostatic free energy of the membrane-solution system is now obtained by sum-
ming up the electrostatic energy in Eq. 2.13 and the entropy of the salt ions in Eq. 2.15.
F
A
=
σ2
40wκ
+
σ2
40wκ
=
σ2
20wκ
(2.16)
which is equal to the free energy we computed using Debye charging method in Eq. (2.12).
This equality assures us that the contribution of the salt ions in free energy is included
in the charging free energy. In principle, we can expand this conclusion to the original
nonlinear PB theory and the charging free energy in Eq. (3.6).
It is worth noting that PB and DH theories rely on some important assumptions: i)
the solvent is considered as a continuous medium with a constant electric permittivity
(dielectric constant), ii) the finite size of the ions is ignored and they are assumed as
point charges, iii) the only interactions between charged bodies is taken to be Coulomb
interactions, iv) any dipole-dipole interaction is neglected, v) the density profile of all ions
ni(r) is a continuous function of r. Another significant note is that PB and DH approaches
neglect the local fluctuations of the charge densities and are thus called mean field theories.
These mean field approaches are, in general, good approximations at most physiological
conditions specially for monovalent ions. In the case of multivalent ions, however, the
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mean field PB should be modified to account for charge-charge correlations because they
are important for multivalent ions.
In this thesis, we deal with a symmetric (1:1) electrolyte solution, but on the membrane
we consider lipid demixing which is a consequence of charge-charge correlation. In order to
incorporate the lipid demixing, we have adopted a non-trivial way within the PB framework
which will be discussed in greater detail in the next chapter.
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Chapter 3
Effect of cell concentration in activity
and selectivity of antimicrobial
peptides
3.1 Introduction
Many cationic peptides such as magainin 2 [26] and melittin [32] (two of the best studied
AMPs) kill bacteria in an all-or-none concentration-dependent manner by forming pores
on the bacterial membrane. But some peptides employ intracellular killing mechanisms
against microbes [17]. For instance, dermaseptin inhibits nucleic-acid synthesis [17]. Nev-
ertheless, membrane lytic peptides are of significant interest, because they use a non-specific
mechanism [12, 10] and thus do not easily induce bacterial resistance. Acquiring resistance
would require the “expensive” work of redesigning lipid membranes [10].
One significant feature of AMPs is their cell selectivity, which enables them to prefer-
entially bind to and kill microbes over the host cells [4, 12]. AMP’s cell selectivity is often
measured by the so-called therapeutic index: the ratio between their minimum hemolytic
concentration (MHC) and their minimum concentration at which bacterial growth is in-
hibited (MIC) [5]. The higher the therapeutic index, the more effective the AMP would
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be as an antibiotic. In general, peptide selectivity (therapeutic index) is improved by de-
creasing their hemolytic activity (higher MHC) or enhancing their bacterial activity (lower
MIC). Accordingly, there have been many attempts to find the parameters that control
the selectivity of AMPs (a comprehensive review can be found in [8]).
Despite its significance in determining the cell selectivity, however, the cell-concentration
dependence of AMP activity has not yet been criticality examined. As pointed out in ref-
erence [8], some confusion remains to be resolved, since the selectivity has often been
measured with different densities of host cells and bacteria. Host cell densities used in
some hemolytic assays are sometimes three orders of magnitude larger than those of bac-
teria [8]. As a result, the selectivity is overestimated. Therefore, a systematic under-
standing of how cell densities would affect the activity and selectivity of AMPs is highly
desirable. Here we offer guiding principles that underlie the cell-concentration depen-
dence of AMP’s membrane-perturbing activity and selectivity. To this end, we present a
coarse-grained model that captures such molecular details as lipid composition and peptide
amphiphilicity-charge.
In this work, the lipid composition of a membrane refers to a varying fraction of anionic
lipids. Cationic peptides interact with such a membrane electrostatically or hydrophobi-
cally. They can form a diffusive layer like multivalent cations or can insert into the interface
between headgroupds and lipid tails in a parallel orientation (with respect to the inter-
face); at high concentrations, they will eventually orient themselves perpendicularly to
form pores [22].
Despite uncertainties about AMP’s microbe-killing mechanisms, their interaction with
membranes deserves much consideration, since the membrane is the first barrier to cross.
Here the main focus is on clarifying how the electrostatic “discrimination” of cationic
AMPs between microbial and host cell membranes varies with cell densities, using the
aforementioned simplified model of peptide-membrane systems. Our effort will help un-
derstand experiments, especially with model membranes, and resolve conflicting views on
cell or membrane selectivity of AMPs [8].
In this chapter, we first develop a free energy approach to the model system and examine
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the effect of cell densities on the cell selectivity of AMPs. Results for MHC and MIC are
discussed in detail and the cell-density dependence of the selectivity is analysed.
3.2 Molecular model
Although the exact mechanism of action of AMPs has not been fully understood yet,
the main physiochemical properties of peptides required for bacterial discrimination and
membrane-disruption have been identified as follows.
i ) Cationic charge, The majority of AMPs possess high levels of cationic residues
in their primary amino acid sequence which enables them to strongly interact with
anionic membrane of bacteria [33]. This cationic charge is also the key tool for cationic
AMPs to specify the anionic membrane of bacteria in a crowd of host cells with almost
neutral membranes [10].
ii ) Amphiphilicity, Another common feature of AMPs is their amphiphilic structure
that is their amino acid sequence constitutes both polar (hydrophilic) and non polar
(hydrophobic) residues [33]. This structural feature gives antimicrobial peptides the
ability to interact more efficiently with the phospholipid membranes having also an
amphiphilic structure (hydrophilic lipid head group and hydrophobic tail).
We have captured these essential properties of AMPs in our coarse-graining. Our peptides
are characterized by a cationic charge Q, and their hydrophobicity is appreciated by a
hydrophobic energy (denoted as I) contributing in the free energy of the system that is
discussed later in this chapter.
Peptides are modelled as positively charged disks on the membrane and as random coils
in bulk. In real lipid-peptide systems, peptides are unstructured in the electrolyte solution
and they are folded to a secondary structure (very often an α-helix) upon binding to the
membrane [34]. The reason is that binding of peptides to membranes is associated with an
environmental change from the aqueous medium (water) to the hydrophobic phase of lipids.
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Formation of an α-helix is generally easier in a hydrophobic environment than in water,
because water destabilizes the intra-molecular hydrogen bonds. Thus, peptide binding is
accompanied by a conformational transition, from random coil in water to an α-helix on
the membrane [35, 34]. In our coarse-graining, the tendency for helical structure formation
on the membrane is incorporated into the free energy gain for hydrophobic interaction with
lipid tails, I , since both of them are promoted in a lipidic environment.
In our approach, the lipid membrane is considered as a two-dimensional binary fluid
mixture of anionic (e.g,. PG) and zwitterionic (neutral) lipids such as PC. Acidic lipids
carry one electrostatic charge, -e, and for simplicity all the lipids are assumed to have the
same head group area, al. Moreover, membrane proteins are not included in our coarse-
graining. The surface charge density of the membrane is determined by the average fraction
of anionic lipids denoted by α¯, that is more specifically, number of charged lipids/total
number of lipids (0 < α¯ < 1). In the absence of bound peptides, neutral and charged
lipids are homogeneously mixed on the membrane. In this state, membrane is treated as a
surface with uniform charge density of σ = −e α¯/al with e the elementary charge and al the
lipid headgroup area. However, biomembranes are actually fluid mixtures of lipids where
lipids can move laterally in the plane of the membrane if needed. In the case of peptide
binding on the membrane, lipid mobility allows anionic lipids to migrate to the vicinity of
the cationic peptides. Thus, concentration of the charged lipids becomes higher in close
proximity of the bound peptide so as to optimize the electrostatic interaction strength
between the peptide and the membrane. This redistribution of lipids is known as lipid
demixing [36]. In our approach we have treated this lipid demixing in a non-trivial way
which will be elaborated later in this chapter.
The membrane is immersed in an ionic solution containing monovalent anions and
cations (e.g., Na+and Cl−), with dielectric constant w. It is basically the dielectric constant
of water as the main component of this salty fluid. The electrolyte solution is in contact
with a salt reservoir such that the salt concentration in bulk is fixed at n0. Furthermore,
the solution contains both peptides and membranes at finite concentrations.
Our approach considers two modes of binding for peptides on the membrane: Surface
adsorption and hydrophobic insertion indicated by mode S and mode I, respectively. Pep-
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Figure 3.1: Illustration of peptides in different binding modes on the lipid bilayer. Pep-
tides in binding mode I are inserted into the interface between lipid head group and tails.
Peptides in binding mode S are electrically bound to the surface. In symmetric binding,
peptides are evenly distributed between the inner and outer monolayers.
tides in binding mode S, are just electrically bound to the membrane where they form a
diffuse layer. As shown in Fig. 3.1 they lie parallel to the plane of the membrane facing
their hydrophilic charged side to the polar head group of lipids. Peptides in the state I
are inserted into the lipid head group-tail interface exposing their hydrophobic part to the
hydrophobic core of the membrane.
The main focus of this thesis is on the peptides in binding mode I, because they have
a major role in the membrane disruption. They are inserted in the interface between lipid
head groups and hydrophobic tails and consequently induce mechanical deformation in the
membrane that, under the right conditions, leads to membrane rupture. Nevertheless, we
consider the electrically bound peptides (in binding mode S) as well, since they affect the
concentration of the peptides in binding mode I through energetics. Peptides in mode S
compete with those in mode I to attract anionic lipids to their vicinities. This competition
due to limited number of lipids on the membrane, as well as peptide-peptide repulsion
between the peptides in different binding modes, influences the density of membrane-
perturbing peptides (in mode I). Hence, the existence of peptides in binding mode S can
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not be neglected.
3.3 Free energy calculation and Wigner-Seitz Cell ap-
proximation
In order to calculate the free energy of our peptide-membrane system, we have used a
mean-field scheme where every bound peptide defines a circular cell, on the membrane,
and the total free energy is the summation of the free energy of individual cells. The total
number of the cells is equal to the number of the bound peptides on the membrane.
As evidenced in experimental works, the density of bound peptides is typically high
enough that peptide-peptide interactions cannot be neglected [37, 38]. In fact, once there
are a large number of peptides on the membrane, there is accordingly a stiff ‘competition’
between bound peptides to attract anionic lipids to their vicinities. Since the membrane
is not an unlimited source of anionic lipids, the aforementioned competition results in
an effective repulsion between like-charged peptides on the membrane. In order to mini-
mize the electrostatic repulsion, peptides are believed to form a hexagonal lattice on the
membrane [9]. Following the same idea, we have adopted a hexagonal lattice model for
peptides bound onto the lipid bilayer. Based on this assumption, peptides on the mem-
brane, regardless of the binding mode they are in, define a two-dimensional Wigner-Seitz
cell (WSC) with radius R as depicted in Fig. 3.2. However, considering a circular WSC for
peptides on the membrane is justified by the fact that biological membranes are actually
fluid, and bound peptides can move on the plane of the membrane (especially when lipid
tails are at the liquid phase) [9]. Therefore, any bound peptide on the lattice, on average,
experiences a radially symmetric distribution of other bound peptides on the membrane
which is captured in a round WSC for each peptide.
The Wigner-Seitz cell model has been widely used to describe the distribution of charged
particles on charged surfaces. May, et al. have used such a cell model to describe the
protein-protein and protein-lipid interactions of charged proteins (modelled as charges
spheres) on the mixed lipid membranes [39]. Taheri-Araghi and Ha have also used this
25
method to consider the interactions of disk-shaped peptides (model of cationic AMPs)
with each other and with the lipid membrane [9]. Considering the WS cell scheme for the
distribution of charged peptides on the membrane is an approximation which is valid in
two limiting cases: when the surface density of bound peptides is so low or when there are
a large number of them on the membrane. In the former, peptide-peptide interactions are
negligible and the system is reduced to a single peptide on the membrane. For such systems,
there is no constraint on the arrangement of the bound peptides and any geometrical
distribution works fine for the peptides on the membrane. At very high surface density of
peptides, lateral interactions between peptides on the membrane are pronounced and they
tend to arrange themselves into a hexagonal lattice on the membrane. In the intermediate
level, however, accuracy of the cell model is reduced due to the lateral fluctuations of the
bound peptides.
Here, we have adopted a semi-analytical approach to compute the free energy. More
specifically, we use an analytical method to calculate the free energy of the WSC as a
function of its radius R and peptide-membrane parameters.
In our cell model, each WS cell contains a uniformly charged disk (model of a peptide)
with radius Rp at its center (see Fig. 3.2). The thickness of the peptides is suppressed,
and in fact our approach can be extended to other geometries provided the thickness is
neglected. The disk peptide is either adsorbed on the surface or inserted into the lipid
headgroup-tail interface. All the cells, regardless of the binding mode of the peptide at
their center, have the same area, Aws, defined as
Aws =
1 + σI AP
σI + σS
(3.1)
where, AP is the area expansion per inserted peptide, and σI(σS) the area density of
the peptides in binding mode I (S). Insertion of the membrane perturbing peptides (in
binding mode I) at the interface between lipid headgroups and tails stretches the membrane
analogous to the effect of an external tensile force, which will be elaborated later in this
chapter. The membrane area increase is related to the density of peptides in binding
mode I, ∆A/A = σI AP , with A the area of the membrane. In other words, if all the
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Figure 3.2: Illustration of peptides hexagonal lattice on the surface (top view)
bound peptides are in binding mode S (σI = 0), the area of the membrane will not change
compared to that of the bare membrane (no bound peptide). However, the induced area
expansion is evenly distributed within the whole plane of the membrane and thus the
area of the WSC, for all bound peptides, is defined as the the total stretched area of the
membrane divided by the total number of bound peptide as it is seen in the Eq. (3.1). Note
that Aws is not only a function of the total number of bound peptides but also the fraction
of peptides in binding mode I. The more peptides in binding mode I, the higher the degree
of membrane expansion and consequently the larger the area of each WS cell would be.
The only difference between cells with peptides at different binding modes is in their
total number of lipids. There are more lipids in a cell consisting of a surface adsorbed
peptide than that of an interface inserted one (in mode I). The reason is that penetration
of the peptide in binding mode I to the lipid headgroup-tail interface will push away the
surrounding lipids as schematically shown in Fig. 3.3
It is worth noting that in the cell model, peptide-peptide electrostatic repulsion on the
membrane have been taken into account in the radius of the WSC, R2 = Aws/pi, explained
as follows. Energetically unfavourable repulsion interactions have a negative effect on
27
Lipids
(A) (B)
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Figure 3.3: Illustration of peptide binding modes on the membrane (side view): (A) mem-
brane inserted (binding mode I), (B) surface adsorbed (binding mode S).
peptide binding. In other words, the higher the inter-peptide electrostatic repulsion, the
lower the number of bound peptides would be on the membrane which, according to the
Eq. (3.1), corresponds to a larger radius for the WS cells. Therefore, smaller radii for the
cells imply weaker repulsive interactions between bound peptides.
Our cell model also considers lipid rearrangement upon peptide binding, which is dis-
cussed in detail in the next section.
3.3.1 Lipid demixing
Membranes are fluid mixtures of anionic lipids which can move in the plane of the mem-
brane and respond to peptide binding. When a cationic peptide binds to the membrane,
anionic lipids are affected by its electric field and, because of their mobility, move to-
wards the bound peptide to neutralize its charge and minimize the energy of the system.
As discussed previously, this electrostatically-driven lipid rearrangement in the vicinity of
bound peptides is called lipid demixing. Deviation of lipids from their homogeneous dis-
tribution, in lipid demixing process, is accompanied by an entropy penalty. The extent of
lipid rearrangement around the bound peptide is indeed determined by the balance of the
electrostatic energy gain and the entropy penalty of lipid demixing. In membranes with
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very low surface charge density (e.g., α¯ = 0.05) the demixing entropy penalty of lipids
dominates the electrostatic energy gain especially for peptides with low charge density and
thus lipid demixing is not very pronounced. In contrast, for membranes with higher charge
density where for instance 20 percent of lipids are charged, lipid demixing has a significant
role in peptide binding [39].
In our approach, as illustrated in Fig. 3.4, we assume that each WS cell is divided into
two main regions: (i) Zone 1 consisting of the bound peptide and surrounding lipids with
total area of As and α1 fraction of anionic lipids. (ii) The second region, zone 2, which
constitutes lipids only with α2 ratio of anionic to neutral lipids.
If lipids are ideally mixed and the local charge modulation of lipids around the bound
peptides is neglected, α1 and α2 will be the same and equal to the average fraction of
charged lipids α¯. However, in the presence of lipid demixing, electrostatic migration of
anionic lipids towards the bound peptide yields a higher fraction of charged lipids in the
vicinity of the peptide, i.e., α1 > α2. Nevertheless, these two quantities are not totally
independent of each other and are found by minimization of the free energy subject to the
constraint that the total number of charged lipids in each WS cell is conserved:∫
Aws
(αi − α¯) da = 0 (3.2)
This integral is carried over the surface of the WSC. However, the lower limit depends on
the binding mode of the peptide at the centre of the cell, which is 0 or Ap for adsorbed and
inserted peptides, respectively. In the above integral, α¯ is the average fraction of charged
lipids and αi indicates the fraction of anionic lipids in each zone, i.e., (i = 1, 2). Note that
αi of each region depends on the binding mode of the peptide as well, such that considering
the α1 as the independent variable, α2 is outputted from the above constraint, as follows
α2I =
α¯ (Aws − Ap)− α1I (As − Ap)
Aws − As
α2S =
α¯ Aws − α1S As
Aws − As (3.3)
29
(A) (B)
Zone 2 Zone 2Zone 1
Zone 2 Zone 1 Zone 2
Figure 3.4: Schematic view of zone 1 and zone 2 of the WSC in the semi-analytical calcula-
tions. (A) The peptide at the center of the WS cell is interfacially bound to the membrane
(binding mode I). (B) The bound peptide is adsorbed onto the surface (binding mode S).
There are less number of lipids in Zone 1 for a peptide in the binding mode I compare to
that of in the binding mode S.
Here, α2I (α2S) is the ratio of charged lipids in zone 2 of a WSC with a peptide at its center
in binding state I (S). As is the area of the zone 1 and Ap is the area occupied by a bound
peptide.
The area of the zone 1, As, is in principle determined by the peptide area and the
area occupied by the surrounding lipids that effectively interact with the peptide. The
area of this effective interaction region around the bound peptide, is read from the two-
dimensional Debye screening length which was introduced by Velazquez and Blum [40]:
κ−12 = al/2pilBα¯, with al the lipid head group area, lB the Bjerrum length and α¯ the
average fraction of anionic lipids. Based on their theory, only lipids within this screening
length interact with the bound peptide effectively. Therefore, for a disk-like peptide of
area Ap = piR
2
p, zone 1 has the area of As = pi(Rp + κ
−1
2 )
2.
All WS cells, irrespective of the binding mode of the peptide, have the same area for the
zone 1, As, but different number of neutralizing lipids in this zone. Insertion of a peptide
into the membrane would naturally push away the lipids and thus there are less lipids in
the zone 1 of a WSC with a peptide in binding mode I compared to that of a peptide in
binding mode S. Consequently, charge neutralization is stronger for the latter as seen in
the Fig. 3.4.
For a bound peptide with cationic charge Q, the charge density of the zone 1 depends
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on the peptide binding mode as following
σ1S =
Q
As
− α1S
al
σ1I =
Q
As
− α1I (As − Ap)
al As
(3.4)
where, σ1S (σ1I) is the charge density of the zone 1 (in units of e) of a WS cell containing
a peptide in binding mode S (I) and al is the lipid head group area.
Planar charge density (in units of e) of the zone 2 which basically constitutes the bare
membrane reads
σ2i = − α2i
al
(3.5)
where α2i is the fraction of anionic lipids in the second zone. As described in Eq. 3.3, it is
defined based on the binding mode of the peptide at the centre of the cell (i= I, S).
Given the charge density of both regions, we can compute the electrostatic free energy
per unit area of each zone using the Poisson-Boltzmann expression for a uniformly charged
surface. This electrostatic energy that was already discussed in chapter 2 has the following
form
Fe(σ) = σΨ0 − κ
pi lB
[
cosh
(
Ψ0
2
)
− 1
]
(3.6)
with Ψ0 the electrostatic potential on the surface defined as
Ψ0 = 2 sinh
−1
(
2piσlB
κ
)
(3.7)
The starting point in our semi-analytical calculations is the total free energy of the WS
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cell, Fws, that is written as
Fws
kBT
= As Fe(σ1) + (Aws − As)Fe(σ2) + I δIi
+ L1
[
α1 lnα1 + (1− α1) ln(1− α1)
]
+ L2
[
α2 lnα2 + (1− α2) ln(1− α2)
]
. (3.8)
The first two terms describe the electrostatic free energy of the WS cell where the
electrostatic charging energy of each zone is given by Eq. (3.6). For WS cells containing a
peptide in binding mode I, there is a free energy gain associated with hydrophobic insertion
of the peptide, which is denoted by I in the third term. This is indeed the parameter
that controls hydrophobic binding of peptides in our model. There is a delta function in
the third term because for those peptides that are electrically bound to the membrane,
i.e., i = S, there is no hydrophobic energy contribution to their binding energy. The last
two terms account for the entropy contribution of lipid rearrangement around the bound
peptide, with L1 (L2) the total number of lipids in zone 1 (2).
Note that the entropy of salt ions and their contribution to the electrostatic energy
is taken into account in the free energy of the WS cell, Fws, through the charging free
energy of each zone, Fe (the relevant discussion is found in Sec. 2.3). Moreover, there is
no contribution from the hydrophobic region of the bilayer and charged particles on the
other side of the membrane in our free energy. In fact, in our calculations, the interior
of the membrane is decoupled from the electrolyte solution, and electric field does not
penetrate into the hydrophobic core of the membrane. This assumption is valid as long as
oil/w  d/λD. The thickness of the lipid bilayers, d, is about 40 A˚ and their dielectric
constant oil is around 2. In our system, the membrane is embedded in an electrolyte
solution with dielectric constant w = 80. The Debye length (λD) is taken to be 10 A˚
as it is the typical screening length under physiological conditions. For such choice of
parameters the decoupling condition is fulfilled. Thus, we can simplify the calculations by
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presuming that there is no interaction between the peptides and salt ions in one side of the
membrane and the other ions and charged particles on the other side of the membrane.
This is equivalent to treating the membrane as an infinitely thick insulator where we can
safely ignore the effect of dielectric discontinuity and the free energy associated with the
lipids and ions on the other side of the membrane.
In our mean field scheme, the free energy of a peptide on the membrane is given by the
WS cell free energy, Fws, however the adsorption or insertion free energies are calculated
with respect to the free energy of the peptide in bulk
F = Fws − Fp (3.9)
where Fp is the free energy of the peptide in bulk, which will be described in Sec. 3.3.2.
Using the free energy of a WS cell with a peptide in binding mode I (S), we can obtain the
corresponding insertion (adsorption) free energy.
Peptides in bulk are modelled as random coils in our approach. Next section is dedicated
to this part of our modelling.
3.3.2 Random coil peptides in ionic solutions
Peptides are basically polymers with amino acids as their building blocks, or monomers.
However, charged polymers (that is the case for cationic peptides) belong to a specific
category of polymers known as polyelectrolytes. When dissolved in a polar solution like
water, these charged polymers (peptides) adopt a random coil structure basically because
of the feasibility of the hydrogen bond formation with water molecules.
The main difference between charged polymers (polyelectrolytes) and neutral polymers
is in the electrostatic interactions that are absent in the latter, but play an important role
in energetics of the former. In the case of positively charged polymers such as our cationic
peptides, the Coulomb repulsion between the charges along the chain tends to expand it.
However, this coil expansion is opposed by the entropy that prefers a compact structure
with more configurational degrees of freedom. The size of the polyelectrolyte chain is then
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determined by the balance of electrostatic interactions and entropy. For polyelectrolytes
in an ionic solutions, there is also electrostatic interactions between the back bone charges
and the salt ions of the solution. Salt ions promote chain compaction by screening the like
charges and thus reducing their electrostatic repulsion. In fact, in the absence of salt ions,
highly charged polymers will adopt a fully extended conformation in solution.
Let the polyelectrolyte molecule have N monomeric units each with length b. In the
Kuhn formalism of polyelectrolytes that we are going to use here, N is the number of Kuhn
segments and b is the Kuhn length. Monomer-monomer interactions in real polymers can
be ignored beyond this length [41]. That is, real polymers can be treated like an ideal
freely jointed chain if they are considered as a collection of N Kuhn segments each with
length b. The polyelectrolyte is carrying a cationic charge Q and is immersed in a (1:1)
electrolyte solution with Debye length λD.
The free energy of this cationic coil in the ionic solution consists of three main terms:
1) configurational entropy of the chain, 2) attractive interactions between polymer charges
and counterions, 3) electrostatic repulsion between the cationic charges on the polymer.
Fcoil = Fconf + Fatr + Frep (3.10)
The configurational entropy of the polyelectrolyte coil is a function of its size which is
expressed by the end-to-end distance, Ree, as following [42]
Fconf =
3
2
kBT
R 2ee
Nb 2
(3.11)
where kB is the Boltzmann constant and T is the temperature.
Electrostatic interactions are computed within Debye-Huckel framework. Following
Ref. [43] we use a simplifying assumption to calculate the electrostatic interactions that
is more valid at high salt concentrations. For not too low salt concentration where the
Debye screening length is small compared to the dimension of the polymer, we can assume
that each charge on the chain is surrounded by a cloud of counterions in the form of a
sphere of Debye radius. We can now apply the Debye charging method to compute the
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electrostatic interaction of charges with their surrounding counterions. In other words,
we charge up our polymer in the ionic solution to its final charge Q and calculate the
corresponding charging free energy. Note that the salt ions in the ionic solution are not
involved in the charging process. As polymer is charging, the counterion spheres, which
are also called ionic atmospheres in the DH theory, are formed around the back bone ions
[44]. The free energy related to the formation of each ionic atmosphere is indeed the Debye
charging energy of a point charge in an ionic solution which is known in the DH theory
[45]. Therefore, the second term in the free energy of the coil Fcoil is given as
Fatr = − Qκe
2
8pi0w
(3.12)
where κ is in the inverse of Debye length, e the elementary charge and w the dielectric
constant of the salt solution. This free energy in units of kBT can be written as a function
of Bjerrum lengh lB = e
2/(4pi0wkBT ) as following Fatr/kBT = −Qκ lB/2.
The repulsive interactions between backbone charges are now screened due to the pres-
ence of the ion atmospheres. These intrachain interactions are calculated for a fixed end-
to-end distance. Let us consider the i-th and j-th charge on the polyelectrolyte that are m
segments apart along the chain. Within the DH theory, their repulsive energy is given as
u ij
kBT
=
lB exp (−κ rij)
rij
(3.13)
where rij is the variable distance between the charges dependent on the molecular config-
uration. However, for any two pair of charges on the polymer we should take an average
on all the possible values of r to find their average interaction energy
u¯ ij =
∫ ∞
0
W (r;Ree,m)uijdr (3.14)
with W (r;Ree,m) the distribution function for the probability of having a distance r
between two charges that are m Kuhn segments apart along a chain with end-to-end
distance Ree. The total repulsive energy of the polyelectrolyte is now obtained by summing
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up the contributions from all possible pair of charges (the detailed derivation can be found
in Ref. [43]). Thus, the last term in Fcoil is written as
Frep
kBT
=
Q2 lB
Ree
ln
(
1 +
6Ree
κNb2
)
(3.15)
Including all the three contributions, the total free energy of the charged coil per units
of kBT is
Fcoil(Ree)
kBT
=
3
2
R 2ee
Nb 2
− Qκ lB
2
+
Q2 lB
Ree
ln
(
1 +
6Ree
κNb2
)
(3.16)
This energy is just a function of polymer end-to-end distance, Ree. The equilibrium
size of the polymer (given by R eqee ) is found by minimization of the free energy in Eq. 3.16
with respect to R ee. The free energy of the polymer at equilibrium will then be Fcoil(R
eq
ee)
which is indeed the peptide free energy in bulk Fp that we have used in Eq. 3.9
3.3.3 Total free energy of the peptide-membrane system
So far we have calculated the electrostatic free energy of a WS cell containing a peptide,
as well as the free energy of a peptide in bulk, however peptide binding is associated with
some other effects that are not included in the WSC energy in Eq. 3.8. One of these effects
that does not depend on the electrostatic interactions is the mechanical deformation of
the membrane induced by bound peptides. In our approach, peptides in binding state S
that are just adsorbed to the head group of lipids, unlike those that bind to the interface,
do not induce any mechanical deformation to the membrane. Peptides in binding state I
that are inserted at the interface between the head group of lipids and their hydrocarbon
chains will then introduce an extra area to the interface, AP , which is concomitant with
a local deformation in the membrane. When bound to the interface, the peptides push
the lipids away and form gaps underneath in the hydrocarbon core of the membrane (see
Fig. 3.1). Lipid tails bend toward the hydrophobic side of the peptide to fill the gap,
and consequently there is a local membrane thinning and bending. The corresponding
range of local deformations has been estimated to be ξ = (16h2KC/KA)
1/4 where h is the
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hydrocarbon thickness of the lipid bilayer, KC the bending modulus and KA the stretch
modulus [46]. If peptide spacing (distance between bound peptides that is 2R in our
model) is smaller than the range of deformations (ξ), the local deformations by individual
peptides on the membrane overlap. In this limit, the membrane thickness decreases almost
uniformly or equivalently the membrane area increases almost uniformly.
In our calculations, we assume the uniform membrane deformation induced by peptide
binding, which is justified by the high concentration of peptides on the membrane. Intro-
ducing AP as the area increase due to binding of one peptide in the I state, the fractional
area stretch in the membrane is then written as ∆A/A = σI AP . The area expansion
induces a stress to the membrane similar to that of an external tensile force. In fact,
the peptide-mediated area expansion could be considered as a tension on the membrane
[21, 20]. The peptide-induced tension on the membrane is sometimes called an internal
tension, simply because it is not due to an external force [46]. Analogous to an external
tension the internal tension in the membrane is defined as τ = KA ∆A/A = KAσIAP
[21]. The relevant deformation energy per unit area of the membrane is then written as
Fstretch/A = 1/2 τ∆A/A = 1/2KA(σIAP )2. This elastic energy contribution is also going
to be included in the total free energy of our membrane-peptide system.
Including all the effects, the total free energy change of the peptide-lipid system upon
binding, per unit area, is expressed as,
∆F
kBT
= σI FI + σS FS + 1
2
KA (σIAP )2
+
[
σI ln(σIAp) + σS ln(σSAp) + (σM − σI − σS) ln
(
1− σI + σS
σM
)]
+
1
NtA
[(
Np −NtA (σI + σS)
)
ln
[(
Np −NtA (σI + σS)
)
vp/V
]
− (Np −NtA (σI + σS))]− Fref (3.17)
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where Fref , the free energy of the reference state, is written as
Fref = Fe(σ0) +
1
al
[
α¯ ln α¯ + (1− α¯) ln(1− α¯)
]
+
1
NtA
[
Np ln
(Np vp
V
)
−Np
]
(3.18)
The first two terms in Eq. 3.17 give the total charging free energy per unit area of the
membrane covered by bound peptides; σI and σS are the planar density of the peptides
in surface adsorbed and inserted state, respectively, and FI(FS) the insertion (adsorption)
free energy defined in Eq. 3.9. The third term describes the membrane elastic energy that is
basically the energy cost for peptide insertion. In this term, KA is the area stretch modulus
of the bilayer, and AP the area expansion per each peptide in binding mode I, which
is equal to Ap or Ap/2 for the symmetric and asymmetric peptide binding, respectively
(this is discussed in detail in Sec. 3.4.2). In the fourth term, translational entropy of the
bound peptides is expressed through a two-dimensional lattice model where, Ap is the
area occupied by a bound peptide and σM = 1/Ap the planar density of binding sites
for peptides on the membrane. The fifth term accounts for the configurational entropy
contribution of free peptides to the free energy; here Nt is the total number of target cells
(either host cell or bacterium), A the area of each target, Np the total number of peptides
in the peptide-lipid system, V the total volume, and vp the volume of a peptide in bulk.
In order to calculate the entropy of peptides in bulk we have used a 3D lattice model
similar to the one used for peptides on the membrane. Furthermore, we have considered a
dilute solution of peptides in bulk, since the concentration of peptides is typically low in the
solution (∼ µM) [33]. Entropy of the solutes in a dilute solution has the well-known form of
S/kBT = N ln(c)−N with N the total number of solutes and c their volume fraction in the
solution. Applying the same entropy to our peptides in the electrolyte solution, N would
be the total number of free peptides and c the volume fraction of free peptides in bulk,
that is the total volume occupied by peptides in bulk/total volume of the system. When
the solution is not connected to a peptide reservoir similar to our system, the number of
free peptide and subsequently their volume fractions is not conserved. Binding of peptides
to the targets will reduce the number of free peptides in the solution. In our approach, the
total number of bound peptides in equilibrium is expressed as NtA (σI+σS) where σI(σS) is
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the equilibrium density of peptides in binding mode I(S) on the cell membranes. Therefore,
the number of peptides that remain free in the solution would be Nfree = Np−NtA (σI+σS)
with Np the total number of peptides in the system.
In Eq. 3.17, the reference energy is subtracted from the total free energy of the system
to give us ∆F . In our approach, the reference state is assumed to be the one in which there
are no peptides on the membranes, i.e., all the peptides are free in bulk. In the free energy
of the reference state defined in Eq. 3.18, the first term is the electrostatic free energy of
the bare membrane that is treated like a flat surface carrying a uniform charge density of
σ0 = −α¯/al (in units of e). Electrostatic free energy of this charged surface denoted by
Fe(σ0) follows Eq. 3.6. The second term gives the translational entropy associated to the
lipid mixture of the membrane, with α¯ fraction of anionic lipids to neutral ones. The last
term accounts for the entropy of the peptides which are all free in the ionic solution in
the reference state. Note that electrostatic energy of each peptide in the reference state
is already included in the adsorption and insertion energies, FS and FI , respectively, in
Eq. 3.17.
Note that in our approach, as seen in the Eq. 3.17, there is no interaction between the
target cells. Furthermore, different types of cells are considered separately (i.e., all the
cells in the solution are similar and, for instance, carry the same fraction of anionic lipids
α¯).
The total free energy of the peptide-membrane system in our model, Eq. 3.17, is actually
a function of four independent variables, σI , σS, α1I and α1S. The equilibrium value of
these variables is found by minimization of the free energy, which was accomplished using
the MATLAB’s optimization toolbox: FMINCON and FMINSEARCH functions.
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3.4 Results and Discussions
3.4.1 Binding isotherms
Minimization of the free energy gives us the equilibrium density of the peptides on the mem-
brane in different binding modes, i.e., σI , σS. However our main focus is on the peptides
in binding mode I that have a major effect in membrane perturbation. More particularly,
we calculate the surface coverage of peptides inserted into the interface between the lipid
head groups and their tails that is denoted by P/L and is defined as the total number of
peptides in binding mode I divided to the total number of lipids on the membrane.
In our calculations, the parameters of the peptide-membrane system are chosen as
follows. Independent of the type of the membrane and peptide, we always have T = 300
K, V = 1L, KA = 0.578 kBT/A˚
2, λD = 10 A˚, and w = 80. For the peptide parameters,
we have used the typical values for Melittin which is a well characterized antimicrobial
peptide with Q = 6, and I = −14 kBT . The volume of the peptides in bulk is given by
the size of the random coils (Sec. 3.3.2) as vp = Ree
3 = 33 3A˚3.
Two different sets of parameters have been used for the membranes, corresponding
to two different types of target cells. To mimic the bacterial membrane we use α¯ = 0.3
(a typical value for a bacterial membrane), al = 71, and Ap = 162, and for the host
cell membrane we have α¯ = 0.05, al = 74, and Ap = 246. The values of al and Ap
are taken from Ref. [22], where the interaction of Melittin with model membranes was
considered. In the bacterial membrane, the average headgroup area of lipids is smaller
than that of the host cells due to abundance of PE (Phosphatidylethanolamine), which is
the principle phospholipid in bacterial membrane [24] and has a smaller headgroup than PC
(phosphatidylcholine) [47] the principle lipid in the membrane of host cells. The different
values of Ap (the area occupied by peptide on the membrane) for different targets is justified
by the dehydration effect [22]. Normally the polar headgroup of lipids are surrounded by
water molecules which are not tightly bound and are released from the headgroup region
when a peptide is embedded in the membrane. Thus the area occupied by the peptide on
the membrane is related to this dehydration effect: the more enhanced dehydration results
40
in the smaller area occupied by the bound peptide. In the bacterial membrane with smaller
lipid headgroup area, more water molecules are released by peptide binding, which leads
to a smaller value for Ap.
Cationic antimicrobial peptides are known to use the compositional difference between
bacterial and host cell membranes to discriminate between them [10, 12]. In the plasma
membrane of bacteria, which is the main target of AMPs, the outer layer is abundant in
anionic lipids whereas in the plasma membrane of host cells, most of the anionic lipids
are in the inner layer facing the interior of the cell. Accordingly, stronger electrostatic
attraction between cationic peptide and negatively charged membrane of bacteria helps
them to differentiate between host cells and bacteria in order to kill the right one. We
have also considered different surface charge densities for the two types of membranes
modelled here. In the bacterial mimicking membrane, thirty percent of the lipids are
negatively charged i.e., α¯ = 0.3 and the host cell- mimicking membrane carries a number
of anionic lipid (α¯ = 0.05) that yield a weak negative surface charge density [9]. As
the first step to investigate the antimicrobial activity and selectivity of Melittin, we have
considered its binding isotherms on different membranes as shown in Fig. 3.5. The molar
ratio of membrane-perturbing peptides in binding mode I to lipids, P/L, is higher on the
bacterial membrane than on the host cell membrane which indeed reveals the selective
membrane-disruption activity of the peptide. Here, we have chosen the target cell density
to be Ct = 5× 105 cells/mL which is a typical cell density in bacterial assays [8], however,
peptide selectivity can be shown for other target densities as well.
To investigate the effect of cell density on peptide binding, as one of the main goals
of this thesis, we have produced binding isotherms for a range of cell densities which are
consistent with those used in the relevant experimental works [8]. Fig. 3.6 and Fig. 3.7
illustrate our results for the bacterial and host cases, respectively. For any target density,
at very large concentration of peptides in bulk, i.e., Cp  Ct, binding isotherms converge
to that of a single target case . Indeed, when there are lots of peptides in the solution,
binding on one cell membrane is not affected by the presence of other cells as if we just
had one single membrane. However, if we decrease the concentration of peptides in the
solution, at some point cells start to ‘see’ each other, that is binding on one cell diminishes
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Figure 3.5: The molar ratio of membrane-embedded peptides (in binding mode I) P/L, a
good measure of membrane perturbing activity of AMPs, as a function of concentration of
peptides in bulk Cp for peptide charge Q = 6. Higher binding of peptides on the bacterial
membrane with α¯ = 0.3 compare to that of the host cell with α¯ = 0.05 is seen in this
figure, which reflects the selective antimicrobial activity of the peptide.
the amount of free peptides for other cells, and thus binding is lowered sharply and goes
to zero for small peptide concentrations.
The effect of cell density on peptide binding is better seen when we fix the peptide
concentration and change the density of target cells . The result is separately displayed in
Fig. 3.8. Our model shows that concentration of target cells Ct does affect peptide binding.
According to our free energy formalism, Eq. 3.17, this is an entropic effect which is seen if
the total number of peptides is fixed in the system. In fact, target density affects peptide
binding by influencing the amount of free peptides. Introducing a density of cells to the
solution is equivalent to reducing the number of “available” free peptides for each cell;
there is a ‘competition’ between cells to attract peptides, recalling that the total number
of peptides is fixed in the solution. Due to this competition, the molar ratio of bound
peptides to lipids on the membrane P/L is lower in a multi-target system than in a single-
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Figure 3.6: The molar ratio of the membrane-disrupting peptides (in binding mode I)
to lipids P/L as a function of peptide concentration in bulk Cp, for α¯ = 0.3 (typical for
a bacterial membrane), peptide charge Q = 6 and various bacterial cell densities Cb as
specified in the figure. By increasing the cell density, binding starts at a higher peptide
concentration. The binding isotherm of the single target case (one cell in the solution)
is also included for comparison. For any cell density, at very high peptide concentration
when Cp  Cb, binding follows the behaviour of the single target case.
43
25x10-3
20
15
10
5
0
P
/L
0.001 0.01 0.1 1 10 100 1000
Cp(µΜ)
single4target
Ch=46 10
24cells/mL
Ch=46 10
34cells/mL
Ch=46 10
44cells/mL
Ch=46 10
54cells/mL
Ch=46 10
64cells/mL
Ch=46 10
74cells/mL
Ch=46 10
84cells/mL
Ch=46 10
94cells/mL
Figure 3.7: P/L as a function of peptide concentration in bulk Cp, for the host cell mem-
brane α¯ = 0.05, peptide charge Q = 6 and various host cell densities Ch as specified in
the figure. Similar to the bacterial membrane case: by increasing the cell density, binding
starts at a higher peptide concentration. The binding isotherm of the single target case
(one host cell in the solution) is also included. For the first three choices of the cell density,
binding is similar to the single target cell (plots lie on top of each other). Nevertheless,
binding isotherms of all the cell concentrations, in general, converge to that of the single
cell case at high concentrations of peptides.
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Figure 3.8: P/L as a function of cell density for the bacterial case (α¯ = 0.3) and a few
choices of bulk peptide concentration Cp. For a fixed Cp, binding is constant at very low
cell densities, it then decreases by increasing the cell density and goes to zero for very large
densities of bacterial cells. However, the cell concentration at which binding is diminished
is higher for a larger value of Cp.
target one. At very low densities (Ct  Cp), however, there is no competition between
cells and binding on target cells does not significantly reduce the number of free peptides
in bulk. Thus, P/L does not change by cell density and is equal to that of a single target
case exposed to Cp concentration of peptides in solution. Nevertheless, by increasing the
number of cells, at some density they start to see each other, which is where the inter-
cell competition starts. Subsequently, peptide binding is decreased by increasing the cell
densities and ultimately goes to zero at very high densities of target cells. As seen in the
Fig. 3.8, the onset of peptide binding attenuation depends on the bulk concentration of
peptide; It occurs at a higher cell density, for larger values of bulk peptide concentration.
In addition, as expected, for a fixed cell density, the larger the Cp the higher the P/L would
be.
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3.4.2 Asymmetric binding of peptides
When electrostatically attracted to the membrane, peptides first bind to the outer leaflet
of the lipid bilayer. However, their amphiphilicity allows them to have hydrophobic in-
teraction with the core of the membrane, which indeed facilitates translocation of the
bound peptides to the inner leaflet of the bilayer and if finally, peptide distribution will be
symmetrized between the two leaflets [48, 24]. Our calculations so far correspond to this
extreme symmetric binding of peptides, which is usually the case in experimental works
that study stacks of parallel lipid bilayers with bound peptides [22]. However, we have also
attempted to make binding isotherms related to the initial asymmetric binding of peptides
on the membrane to see how symmetrization influences peptide activity.
In order to simulate the asymmetric binding of peptides, we needed to make some
changes to our model. We believe that the elastic energy of the membrane is defined
differently based on the symmetry of peptide binding. In asymmetric binding, there are
no peptides in the inner layer and all the peptides bind to the outer layer. In this case, the
mechanical deformation of the membrane induced by peptide binding is shared between the
two monolayers which is explained as follows. Insertion of peptides at the interface between
lipid headgroups and tails stretches the membrane, however in the asymmetric binding, this
will be accompanied by the expansion of lipids in the inner layer as well. This energetically
unfavourable lipid expansion in the inner layer is balanced with the compression of lipids in
the outer layer such that, in the end, the membrane area is stretched by AP/2 per inserted
peptide. Accordingly, the mechanical deformation term in the free energy of the system
would be altered as 1/2KA (σIAp/2)
2. This is indeed analogous to a one dimensional
system of two identical parallel springs each with length x0 which are coupled to each
other such that any compression or expansion in one them will directly affect the length of
the other one too. Now if an object of length L is added to one of them, the final stretched
length of the two strings will be x = x0 + L/2.
By conserving the total number of lipids, the reduced area per lipids in the outer layer
is estimated to be a ′l = al (1 − σI Ap/2). Therefore, in asymmetric binding analysis, we
will use this shrunk headgroup area instead of al in our free energy in Eq. 3.17. Note that
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Figure 3.9: P/L as a function of bulk concentration of peptides Cp, for peptide charge Q
= 6, α¯ = 0.3 and Ct = 5× 105 cells/mL. In the symmetric binding, there are less number
of peptides to lipids on the outer layer, compared to the asymmetric case.
we always consider binding of peptides on the outer layer (although it is not an issue in
symmetric binding, because peptide concentration is the same on both layers).
In addition, since peptides just bind on the outer layer in the asymmetric binding, the
total number of peptide binding sites on the membrane is half of those in the symmetric
binding. Accordingly, the membrane area A will be altered to A/2 in the asymmetric bind-
ing. Plugging all the aforementioned changes to the free energy of the peptide-membrane-
solution system in Eq. 3.17, and minimizing it ( similar to what we did for the symmetric
binding), we have made binding isotherms for the asymmetric binding of Melittin on the
membranes. Fig. 3.9 shows our results. In the symmetric binding case, distribution of
peptides between the two monolayers along with a higher elastic energy of the membrane
results in a lower number of bound peptides to lipids, P/L, in the outer layer compared
with the asymmetric binding of peptides. In both cases, however, P/L is saturated for
large concentrations of peptides in bulk. The saturation value in the asymmetric binding
is almost twice as much as in the symmetric one.
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3.4.3 Peptide selectivity: therapeutic index
The main feature of antimicrobial peptides is that they selectively rupture the membrane of
bacteria over that of host cells. In this section we consider the effect of target concentration
on peptide selectivity or more specifically on the peptide therapeutic index.
Therapeutic index is a good measure of peptide selectivity which is defined as MHC/MIC
where MHC is the minimum haemolytic concentration of the peptide for the host cells and
MIC its minimum inhibitory concentration for the bacteria. MIC and MHC are, in fact,
the bulk concentrations of the peptides at which they effectively rupture the membrane of
bacteria and host cells, respectively.
It has been observed in experiments that AMPs are inactive against their targets below
a threshold concentration on target membranes, which we denote by P/L∗ [20, 22]. In
other words, for P/L below P/L∗ no pore was observed on the membrane, but as P/L
exceeds P/L∗ transmembrane pores appeared on the membrane [22]. Thus, there seems to
be a correspondence between the two critical peptide concentrations described as follows
[33]. Regarding the antibacterial activity of the peptides, if the total concentration of the
peptides in solution is around MIC, (i.e., Cp ≈ MIC ), the concentration of the peptides on
the membrane is close to the threshold concentration, that is P/L ≈ P/L∗, and a similar
thing applies when the targets are host cells for which MIC is substituted by MHC.
In what follows, we use our binding isotherms and the aforestated relation between the
threshold concentrations of the peptides to calculate their therapeutic index. Given the
P/L∗ for bacteria and host cells, we can exploit our results in figures 3.6 and 3.7 to extract
the corresponding peptide concentration in bulk which is MIC or MHC respectively, and
thus compute its therapeutic index. However, the question is now how should we select
P/L∗ for different targets? More particularly, is the peptide threshold surface coverage
required for rupture the same for the membrane of bacterial and host cells?
To answer this question, we should figure out if the the lipid compositional differences
between the membrane of bacteria and host cells can affect the threshold rupture concen-
tration of the peptide P/L∗.
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3.4.4 Lipid packing shape and threshold surface coverage
A universal characteristic of membrane-lytic antimicrobial peptides is their cooperativity
that is independent of their mode of action, a threshold concentration P/L∗ is required for
their activity below which no significant effect can be seen [20, 33]. They are, therefore,
said to disrupt the membrane in a so called all-or-none concentration dependence manner
[16].
On the correlation between the peptide critical concentration P/L∗ and lipid composi-
tion, our first question was how do charge properties of the membrane affect the rupture
concentration of peptides? The answer of this question was found in the work of Weiprecht,
et al. [49]. They studied the interaction of the cationic peptide PGLa with neutral and
negatively charged model membranes and showed that membrane charge will just affect
the initial binding of the peptides. In fact, by excluding the electrostatic interactions and
focusing on the surface concentration of the peptides instead of their bulk concentrations,
they obtained the same threshold concentrations for peptides on both anionic and neutral
membranes. Thus, it appears that P/L∗ does not depend on the charge of the membrane.
Nevertheless, Huang did more systematic analysis to explore the lipid dependence of
collective activities of AMPs. His group studied the interaction of different AMPs with
model membranes of various lipid compositions and measured the threshold P/L∗ of the
peptides via different experimental methods [22, 21]. Their measurements showed that
the peptide concentration required for membrane rupture P/L∗ does depend on the lipid
composition of the membrane. More specifically, they studied model membranes with
different concentrations of positively curved lipids (lysoPC) or negatively curved ones (PE)
and observed that peptide threshold concentration P/L∗ is larger for membranes consisting
of higher amounts of negatively curved lipids (lipid curvature was described in Sec. 1.3)
[22]. This was consistent with the earlier observations where addition of PE inhibited
formation of toroidal pores by magainin and melittin while addition of lysoPC facilitated
their formation [26, 19]. The idea was that lipid curvature correlates with the curvature of
the pore, and thus formation of toroidal pores with a mean positive curvature is facilitated
by lipids of positive curvature (lysoPC) and is prevented by lipids of negative curvature
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(PE). However, Huang et al. observed the same lipid dependence for both melittin (with
toroidal pores) and alamethicin (with barrel-stave pores) systems [22]. This interesting
observation therefore shows that the effect of lipid curvature on pore formation must be
through something other than the pore curvature because alamethicine pores are known
to have a zero curvature.
Based on the large extent of research on the widely studied AMPs alamethicin, melit-
tin, magianin and protegrin, Huang proposed a two-state model to explain the collective
antimicrobial activity of peptides which indeed enabled him to clarify the lipid dependence
of P/L∗ as well [20].
According to his model, there are two binding states for peptides on the membrane:
surface state S with energy level −ES and pore state P with energy level −Ep, where,
in general ES > Ep (i.e., the surface state is more stable than the pore state) [20]. Not
to be confused with our binding model of peptides, the surface state here refers to the
membrane perturbing peptides (equivalent to our binding mode I). In fact, surface adsorbed
peptides are not considered in this model since they have a minor impact on membrane
perturbation. When the concentration of peptides is below the threshold concentration, all
the bound peptides occupy the surface state where they are embedded in the membrane
and concomitantly increase the membrane area. This energetically unfavourable membrane
area stretch is assumed to be equivalent to a membrane tension that scales with P/L.
Therefore, a positive term which increases with P/L is added to the energy level of the S
state. Peptide binding then increases the energy level of the S state and eventually, once
the concentration of the peptides on the surface reaches the threshold P/L∗, the energy
level of surface state becomes higher than that of the pore state. Consequently for P/L
above P/L∗, all the excessive peptides will directly go to the pore state, that now has a
lower energy than the S state, and contribute to pore formation.
Within his two-state model, Huang has obtained the threshold concentration as P/L∗ =
(ES−EP )/KA(A2p/al)(1−β), where KA is the area stretch modulus of the lipid bilayer, Ap
the membrane area expansion per bound peptide (in the S state), al the area of the lipid
headgroup and β is a parameter that determines the contribution of pores in the membrane
thickness [20, 22]. Measuring all the above experimental parameters related to P/L∗ and
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analysing the data, his group eventually found the underlying reason of lipid dependence
of P/L∗. Regardless of the type of peptide, a strong correlation was observed between the
variations of P/L∗ and the membrane thinning effect quantified by Ap [22]. The smaller
the Ap, the larger the threshold concentration P/L
∗ is for both type of pores. Thus, Ap is
a dominant factor in determining the lipid dependence of P/L∗.
Membrane thinning measurements for various peptide-lipid systems show thatAp strongly
depends on the lipid composition. It is smaller in membranes with higher amounts of neg-
atively curved lipids [22]. As a result, the higher the concentration of lipids of negative
curvature in the membrane, the larger number of peptides are required for membrane
disruption (a larger P/L∗).
The lipid dependence of Ap is believed to be due to the lipid dehydration effect of
peptide binding. When peptides bind to the membrane, some water molecules are released
from the headgroup region of lipids and thus reduce the area expansion by the peptides.
For negatively curved lipids, where their headgroups have a smaller cross sectional area
than their hydrocarbon chains such as PE (see Sec. 1.3), there are more water molecules
surrounding the headgroups compare to positively curved lipids. Therefore, more water
molecules are released from the headgroup of negatively curved lipids by peptide binding
than from the positively curved ones. Consequently addition of PE to the membrane
decrease Ap whereas addition of LysoPC (a positively curved lipid) increases it [22].
Huang et al. studies indeed shed light on a universal effect of lipid spontaneous cur-
vature on the pore formation activity of AMPs. During their extensive studies on AMPs,
they also measured significant parameters of various peptide-lipid systems that are related
to pore formation. We have also used some of their melittin-lipid parameters in this thesis.
We can now answer the question about the difference between the threshold concen-
tration of AMPs on the host cells and bacterial membrane. According to the universal
curvature effect of lipids and the fact that PE (with negative curvature) is the principal
phospholipid in bacteria while in the host cells PC (with zero curvature) is the main lipid
constitution, we conclude that the threshold peptide concentration P/L∗ is larger for the
bacterial membranes than host cells.
51
In our model, we have implicitly captured the lipid curvature difference between the
membranes of host cells and bacteria through a parameter, Ap, that represents the area
occupied on the membrane by bound peptides. The degree of membrane mechanical de-
formation induced by peptide binding is also quantified by Ap, in our approach. The
membranes of bacteria are rich in PE while the host cell membranes are abundant in
PC, thus according to the curvature effect of lipids, peptides are better accommodated in
the former. We have taken into account this difference by choosing a smaller Ap on the
membrane of bacteria than that of host cells.
Huang’s group has measured P/L∗ of the Melittin on PC and PC/PE model membranes
[22] that are the commonly-used lipid compositions to mimic the host cell and bacterial
membrane, respectively. Using their experimental parameters, we take the threshold con-
centration of Melittin to be P/L∗ = 1/48 on the bacterial membrane and P/L∗ = 1/99 on
the host cell membrane [22].
Given the threshold concentration P/L∗ of the peptide on the membrane, we can now
use our binding isotherms, as shown in the Fig. 3.10, to extract the corresponding bulk
values which are indeed MHC and MIC.
Doing the binding calculations for varying cell densities enabled us to elicit MIC and
MHC for different cell densities. Fig. 3.11 depicts our results for MIC and MHC as a
function of cell density. Both MHC and MIC increase with increasing cell density. This
concentration-dependence activity of AMP can be understood as follows: since the total
number of peptides is conserved, peptide biding is influenced by cell density. The higher
the cell density, the fewer bound peptides (this was already shown in Fig. 3.8, and the
relevant discussion is found in the Sec. 3.4.1). Therefore, at a higher cell density, more
peptides in bulk will be required in order for P/L to reach the threshold value P/L∗ for
membrane disruption. Consequently, MIC and MHC are higher at higher cell densities.
For minimum hemolytic concentration MHC, we considered two different cases: (1)
host cells have the same area as the bacteria, (2) area of the host cells, AH , is larger than
that of the bacteria,AB, by a factor of 17. In the first case, we have chosen the target areas
as AH = AB = 12 × 10−12m2, which is twice the surface area of E. coli. The factor two
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Figure 3.10: (a) Extraction of MIC for peptide charge Q = 6 and various densities of
bacteria. (b) Extraction of MHC for various densities of host cells and peptide charge Q
= 6. In both cases, we have used the experimental data for P/L∗.
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Figure 3.11: (a) MHC as a function of cell density for peptide charge Q = 6 and two choices
of cell area as specified in the figure. (b) MIC as a function of cell density for Q = 6 and
target membrane area AB = 12× 10−12.
is needed for the symmetric binding of peptides on the membrane, because peptides bind
onto both leaflets of the lipid bilayer. However, in reality host cells (red blood cells) are
larger than bacteria. The surface area of a red blood cell is of the order of 10−10m2. Thus,
we did calculations for a more realistic situation as well, where AH = 17AB. Fig. 3.11
shows MHC as a function of cell density for the two different choices of cell area.
MHC increases by increasing the host cell area for the same reason as it increases by
increasing the cell density. In fact, in our multi-target analysis, increasing either of the cell
surface area or number of the cells increases the total number of peptide binding sites (given
by NtA), and thus produces the same effect. In principle, in our model (see Eq. 3.17) we
can combine these two parameters into just one parameter which is equivalent to reducing
our multi-cell system to a single cell with a large area of A = NtA. Therefore, increasing
the cell area has the same effect in our calculations as increasing the cell density. Thus,
in our area basis analysis, instead of increasing the area we can increase the cell densities
accordingly. More specifically, in Fig. 3.11, we can obtain either of our MHC curves from
the other one by rescaling the x axis (cell densities).
Using the results for MHC and MIC, it is now possible to investigate the effect of cell
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Figure 3.12: MHC/MIC, a good measure of peptide selectivity, as a function of cell con-
centration for peptide charge Q = 6 and two different choices of host cell area AH as
determined in the figures. (a) Both host cells and bacteria have the same cell densities.
(b) Host cells have a fixed cell density NH while bacterial density is varying. Regardless
of the choice of cell densities, peptide selectivity is higher for a larger host cell area.
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density on peptide therapeutic index defined as MHC/MIC. Fig. 3.12 displays our results
for peptide selectivity (MHC/MIC) as a function of cell concentration. We have chosen
the density of different target cells in two different ways: (1) density of both host cells
and bacteria is the same, (2) density of host cells is fixed and bacterial concentration
varies. The second density profile is closer to reality, because it is the concentration of
bacteria that changes depending on the degree of infection, and host cells have almost a
fixed concentration. As shown in the Fig. 3.12, for both choices of cell densities, peptide
selectivity is influenced by cell densities; it decreases as the concentration of cells increases.
In addition, peptide selectivity (MHC/MIC) is higher for a higher host cell area. The
reason is that MHC increases by increasing the area of host cells as seen in Fig. 3.11.
To understand the underlying reason for this decreasing behaviour of peptide selectivity
by cell density, we repeated our calculations within the simpler Langmuir binding model
for the interaction of peptides with the membranes. This model is described in detail in
the Appendix B. In the Langmuir binding model, peptide binding is driven with a binding
energy w which is dependent on the type of the targets; it is larger on the bacterial
membrane than host cells. Analogous to what we did in our full analysis, we calculated
the molar ratio of bound peptides to lipids P/L as a function of bulk concentration of
peptides for different targets. MHC and MIC were then extracted from the binding curves
for varying cell densities. Fig. 3.13 depicts the results for MIC and MHC as a function
of cell density. Both MIC and MHC increase as cell density increases. The reasoning is
exactly the same as the one given for the results in Fig. 3.11, since this model also considers
a fixed number of peptides.
In the end, peptide selectivity (MHC/MIC) was computed for different cell densities.
The results are illustrated in Fig. 3.13c. Analogous to our previous approach, the ratio
MHC/MIC, which is the measure of peptide selectivity, decreases by increasing the cell
density. In order to find out how the choice of peptide threshold concentration P/L∗
affects this cell concentration dependence of peptide selectivity, we did the calculations
for various choices of P/L∗. More specifically, the peptide threshold concentration on the
bacterial membrane P/L∗B is chosen to be either similar to that on the host cell P/L
∗
H or
different. As shown in the Fig. 3.13c, regardless of the choice of P/L∗, peptide therapeutic
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Figure 3.13: Cell concentration dependence of peptide selectivity within the Langmuir
binding model: (a) MHC as a function of cell density for different choices of peptide
threshold concentration P/L∗ as specified in the figure. (b) MIC as a function of cell
density for the two different values of P/L∗. (c) MHC/MIC as a function of cell density
for different choices of P/L∗ on the membranes as specified in the figure.
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index (MHC/MIC) decreases as cell density increases. At very high densities, however,
it reaches a plateau. The value of this plateau is determined by the choice of P/L∗: For
the same threshold concentration on bacterial membrane and host cell, it occurs at 1.
Otherwise, it happens at a different value depending on the choice of P/L∗.
In an attempt to understand the reason of the cell concentration dependence of peptide
selectivity, we carefully tracked the changes of MIC and MHC by varying the cell density.
As shown in the Fig. 3.14, we observed that for a fixed P/L∗ the gap between the two
P/L curves, which is in fact the difference between MIC and MHC, does not significantly
change by changing the cell density. Note that in the figure the log scale falsely gives the
appearance of significant change in δ. However, as shown in the Fig 3.15, using a linear
scale, it is easily seen that the gap remains the same for various cell concentrations. Thus
peptide therapeutic index can be expressed as MHC/MIC = (MIC + δ)/MIC, where δ is
fixed and does not depend on the cell density. Therefore, the cell-concentration dependence
of the MIC determines the cell concentration dependence of the ratio. As shown in the
Fig. 3.13b, MIC increases as cell density increases and as a result the ratio, which measures
the peptide selectivity, decreases by increasing the cell density. However, at high cell
densities where MIC δ, the ratio converges to one.
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Figure 3.14: P/L as a function of Cp for two different targets: microbe (w = −25.32), and
host cell (w = −19). Peptide binding on two targets is compared for a few choices of cell
densities Ct. The gap between the curves δ does not change by increasing the cell density.
59
(a)
10.20x10-3
10.15
10.10
10.05
10.00
P
/L
60x10-650403020100
CP (µΜ)
w = -25.32
w = -19
δ
(b)
10.20x10-3
10.15
10.10
10.05
10.00
P
/L
1.73x10-31.721.711.701.691.681.67
CP (µΜ)
w = -25.32
w = -19
δ
Figure 3.15: (a) Zoom-in plot of Fig. 3.14a for cell density Ct = 6 × 102 cells/mL. (b)
Zoom-in plot of Fig. 3.14e for cell density Ct = 6× 106 cells/mL. Regardless of the cell
density the gap between the two curves is of the order of 10−5µM
Comparison of the results from the single-binding site model with those from the coarse-
graining indicated the effect of electrostatic interactions in the cell-concentration depen-
dence of peptide selectivity. Fig. 3.16 depicts MHC/MIC as a function of cell density,
computed from two different models. As shown in the figure, except for the very low
concentrations, there is good agreement between the results of the two models. Thus,
electrostatic interactions do not affect the decreasing behaviour of peptide selectivity by
cell density. As seen in the figure, they just cause saturation of the peptide selectivity at
low concentrations.
Because of the good agreement between the two models, the reasoning originally pro-
posed for the decreasing trend of peptide selectivity for the Langmuir binding model can
be extended to the full analysis.
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Figure 3.16: MHC/MIC as a function of cell density from two different models: the full
analysis based on electrostatic interactions and the Langmuir binding model.
3.5 Summary and Conclusion
To summarize, we presented a physical model for the cell concentration dependence of
AMP’s activity and cell selectivity. We accomplished this by developing a theoretical model
that considers a few pronounced interactions of peptides with lipid bilayers. To investigate
the effect of cell density on antimicrobial activity of the peptides, we first calculated the
molar ratio of the membrane perturbing peptides, those that are bound to the interface
between lipid head group and tail, for various peptide and cell densities. This enabled
us to extract the required components to calculate the peptide selectivity: The peptides’
minimum hemolytic concentration (MHC) and their minimum concentration that inhibits
the growth of bacteria MIC. We showed that both MIC and MHC increase as cell density
increases. An increase of MIC means that the peptide activity diminishes as cell density
increases. Peptide selectivity was then studied by computing the peptide therapeutic index
defined as therapeutic index = MHC/MIC for various cell densities. Our results showed
that peptide selectivity is also affected by the cell density; selectivity decreases as cell
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density increases.
To discover more about the cell concentration dependence of antimicrobial activity
of AMPs, we considered a single-binding site model for the interaction of peptides with
the membranes. In this model, many body interactions and peptide-induced mechanical
deformation were turned off, and peptides interacted with the membranes only through
a fixed binding energy; binding energy was higher on the bacterial membrane than on
the host cells. Interestingly, we achieved the same cell concentration dependence for the
peptide selectivity using this model. The agreement between the two models led us to
the conclusion that the decrease of peptide selectivity with increase of cell density is a
general feature of peptide-membrane systems; regardless of the nature of the interactions,
the different binding affinity of the peptides for the targets results in a decreasing trend
for cell selectivity as a function of cell density.
According to our results, cell selectivity is not an intrinsic feature of antimicrobial
peptides as it is attenuated by increasing the cell concentration. Some peptides may even
lose their selectivity at very high cell concentrations. Therefore, cell selectivity analysis
needs to be done with caution as choosing the wrong host and microbial cell concentrations
would result in an inaccurate estimation of the peptide selectivity.
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Appendix A
Entropy of the salt ions interacting
with a charged surface in a (1:1)
electrolyte solution
In an electrolyte solution, the entropy of the salt ions is given as follows
Fent = kBT
[ ∫ [
n+ ln
n+
n0
+ n− ln
n−
n0
− (n+ + n− − 2n0)
]
dr (A.1)
where kB is the Boltzmann constant, T the temperature, n+(n−) the density of cations
(anions), and n0 the density of salt ions far from the membrane.
As discussed in chapter 2, the density of the salt ions obeys the Boltzmann distribution
n±(r) = n0 exp(∓e ψ(r)/kBT ) (A.2)
where e is the electrostatic charge, and ψ(r) the electrostatic potential at position r.
In the case of a weakly charged surface in the solution, the electrostatic potential
and consequently the density of the ions is obtained using the Debye-Huckel theory. As
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discussed in Sec. 2.2, the electrostatic potential is written as
ψ(z) =
σ
0wκ
exp(−κz) (A.3)
where σ is the surface charge density, 0 the electric permittivity of vacuum, w the dielectric
constant of the aqueous solution, and κ the inverse of the Debye length. In fact, symmetry
of the planar geometry reduces the system to 1-dimension, where the electric potential and
the ion densities are only a function of the vertical distance from the surface denoted by z
(n±(z), ψ(z)).
Here, we postpone using the functional form of the potential until the end of the
calculation as it would not be clean to substitute it at the beginning. Thus, using the ion
densities in Eq. A.2, the entropy in is computed as
Fent = An0kBT
[ ∫ ∞
0
2
eψ(z)
kBT
sinh(
eψ(z)
kBT
)dz +
∫ ∞
0
[− 2cosh(eψ(z)
kBT
) + 2
]
dz
]
(A.4)
where A is the surface area.
In the case of a weakly charged surface, eψ(z)/kBT  1, Eq. A.4 can be further simpli-
fied by using the Taylor expansion of the hyperbolic functions. We keep the approximation
to the second order of ψ.
Fent = An0kBT
[ ∫ ∞
0
2(
eψ(z)
kBT
)2dz −
∫ ∞
0
(
eψ(z)
kBT
)2dz
]
= An0kBT
∫ ∞
0
(
eψ(z)
kBT
)2dz
= An0kBT
∫ 0
ψ0
(
eψ
kBT
)2(− 1
κψ
)dψ
=
An0e
2ψ20
2kBTκ
=
Aσ2
4w0κ
(A.5)
Note that in the third line, we have changed the variable of integration. In the last line
two substitutions have been used: the surface potential ψ0 = σ/0wκ using Eq. A.3 and
κ2 = 8pin0e
2/(4piw0kBT ).
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Appendix B
Langmuir binding model
In this model, which is in virtue similar to the Langmuir adsorption model [30], peptide
binding is driven by a fixed binding energy indicated as w. There is no interaction between
the bound peptides on the membrane. In addition, the total number of peptides in the
solution is fixed; there is no peptide reservoir and thus binding on the membranes decreases
the concentration of free peptides.
The chemical potential of the peptides bound to the membrane, µb, is then written as
µ b = kBT
[
w + ln
( σAp
1− σAp
)]
(B.1)
where kB is the Boltzmann constant, T the temperature, w the binding energy, σ the
area density of the bound peptides, and Ap the area occupied by a bound peptide. The
second term describes the translational entropy of the bound peptides, which is obtained
by considering a 2D lattice model; the membrane is assumed to be like a 2D lattice with
the total number of peptide binding sites defined as S = A/Ap, where A is the membrane
area. Indeed, σAp gives the area density of the filled binding sites.
In this model, we consider a dilute solution of peptides and cells. Thus, there is no in-
teraction between the free peptides or between the cells. Note that the electrostatic energy
of each free peptide is subsumed in its binding energy. Thus, we have only translational
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entropy associated with the free peptides and their chemical potential has the form
µf = kBT ln[(Cp − CtσA)vp] (B.2)
where Cp is the total concentration of the peptides in the solution, Ct the concentration of
the target cells, A the area of each cell, and vp the volume of a free peptide.
Balancing the two chemical potentials, we obtain a Langmuir-like binding equation
σAp =
(Cp − CtAσ)K
1 + (Cp − CtAσ)K (B.3)
with K the binding constant defined as K = vp exp(−w/kBT ). Here, the concentration
of free peptides in bulk, which is given inside the parentheses of the equation, is indeed
dependent on the number of bound peptides because the total number of peptides is con-
served.
In order to find σ as a function of Cp, we should solve the Eq. B.3 for σ which results
in the following equation
− CtAK Apσ2 +
(
Ap +K ApCp + CtAK
)
σ − CpK = 0 (B.4)
It is worth noting that there are two solutions for Eq. B.4, however, our desired solution
is the one that fulfils σ 5 1/Ap, i.e., σ can not be larger than the area density of the
peptide binding sites on the membrane. To rewrite the Eq. B.4 as a function of ratio of
bound peptides to lipids P/L, we just need to make the following conversion everywhere
σ = (P/L) 1/al, where al is the lipid head group area.
In this model, w is the only parameter which depends on the type of the target. Peptides
have a higher binding energy w on the bacterial membrane than on host cells because
of stronger electrostatic interactions with the former. We have obtained w for different
targets by fitting the P/L from Eq. B.4 to the binding isotherms we obtained from the
coarse-grained approach. The result is as follows; for the bacterial membrane w = −25.32,
and for the host cell w = −19.
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Appendix C
The MATLAB Code used in the
project
clc
clear a l l
global Q a l alph kapain Cp ap apef lb rp
Eps = 8.85 e−12;
T = 300 ;
Kb = 1.38∗1 e−23;
Dw = 80 ;
NA = 6.023∗1 e +23;
e = 1 .6 e−19;
lb = e ˆ2∗1 e +10/(4∗pi∗Eps∗Dw∗Kb∗T) ;
kapain = 10 ; %Angstrom
C 0 = 1/( kapain ˆ2 ∗8∗pi∗ lb ) ;
%Me l i t t i n
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a l = 71 ; %74 , 65
ap = 162 %246 , 314
apef = ap ; %symmetric b ind ing
%ape f = ap/2 f o r asymmetric b ind ing
SM = 1/ap ;
alph = 0 . 3 ; %0.05
Q = 6 ;
rp = sqrt ( ap/pi ) ;
lambda = a l /(2∗pi∗ lb ∗alph ) ;
As = pi ∗( rp+lambda ) ˆ2 ;
%Host
%s i n g l e t a r g e t
%c p = [ 0.0001 0.00012 0.0002 0.0003 0.0005 0.0007 0.001 0.005
0.01 0.03 0.05 0.1 0.3 0 .7 0 .9 1 3 4 5 7 9 10 15 20 30 40 50
60 70 80 90 100 200 300 400 500 600 700 800 900 1000 2000
3000]
%N h = 6e2 − 6e5
%c mic = [ 1e−4 1.2 e−4 2e−4 3e−4 5e−4 7e−4 1e−3 2e−3 3e−3 4e−3 5e
−3 7e−3 0.01 0.03 0.05 0.1 0.3 0 .7 0 .9 1 3 4 5 7 9 10 15 20 30
40 50 60 70 80 90 100 200 300 400 500 600 700 800 900 1000
2000 3000]
%N h = 6e6
%c mic = [ 1e−4 2e−4 3e−4 5e−4 7e−4 1e−3 2e−3 3e−3 4e−3 5e−3 7e−3
0.01 0.014 0.017 0.023 0.026 0.03 0.04 0.05 0.1 0.3 0 .7 0 .9 1
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3 4 5 7 9 10 15 20 30 40 50 60 70 80 90 100 200 300 400 500
600 700 800 900 1000 2000 3000]
%N h = 6e7
%c mic = [ 7e−4 1e−3 2e−3 3e−3 4e−3 5e−3 7e−3 0.01 0.014 0.017
0.023 0.026 0.03 0.04 0.05 0.07 0.1 0.13 0.17 0.2 0.32 0.35
0.4 0 .5 0 .6 0 .7 0 .9 1 3 4 5 7 9 10 15 20 30 40 50 60 70 80 90
100 200 300 400 500 600 700 800 900 1000 2000 3000]
%N h = 6e8
%c mic = [0 .017 0.023 0.026 0.03 0.04 0.05 0.07 0.1 0.13 0.17 0.2
0.32 0.35 0.4 0.5 0.6 0.7 0.9 1 1.3 1.5 2 2.5 2.6 3 .7 3 .8 4 5
7 9 10 15 20 30 40 50 60 70 80 90 100 200 300 400 500 600 700
800 900 1000 2000 3000]
%N h = 6e9
%c mic = [ 0 . 1 0.13 0.17 0.2 0.32 0.35 0.4 0 .5 0 .6 0 .7 0 .9 1 1.3
1 .5 2 2.5 2 .6 3 .7 3 .8 4 5 7 9 10 15 20 30 35 37 40 43 45.8 46
50 60 70 80 90 100 200 300 400 500 600 700 800 900 1000 2000
3000]
%Bacter ia
%s i n g l e t a r g e t
%c mic = [1 e−6 3e−6 6.7 e−6 9.854 e−6 1.2 e−5 2.34 e−5 3.5 e−5 5e−5
8.876 e−5 1e−4 3.788 e−4 6e−4 9e−4 1e−3 3e−3 9e−3 2e−2 4e−2
6e−2 0.1 0.3 0.5 0.7 1 3 6 8 10 20 30 50 60 80 100 ] ;
%N b = 6e2 , 6e3 , 6e4
c mic = [ 1 e−6 3e−6 6 .7 e−6 9 .854 e−6 1 .2 e−5 2 .34 e−5 3 .5 e−5 5e−5
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8 .876 e−5 1e−4 3 .788 e−4 6e−4 9 .9101 e−4 3.79094 e−3 9.82101
e−3 2.05505 e−2 4 .5557 e−2 6.25669 e−2 9.73273 e−2
0.143712 0.203657 0.279167 0.372308 0.485207
0.620045 0.779055 0.964523 1.17878 1 .4242 1.70321
2.01826 2.37187 2.76657 3.20495 3 .6 6 7 8 10 20 30 40
50 60 80 90 100 ] ;
%N b = 6e5
%c mic = [ 4e−6 5e−6 8e−6 1.2 e−5 2.34 e−5 3.5 e−5 5e−5 6e−5 8.876
e−5 1.3 e−4 2e−4 3.788 e−4 5e−4 6e−4 9.9101 e−4 1.3 e−3 1.5 e−3 2
e−3 3e−3 3.79 e−3 9.82101 e−3 2.05505 e−2 4.5557 e−2
6.25669 e−2 9.73273 e−2 0.143712 0.203657 0.2 0.372308
0.485207 0.620045 0.779055 0.964523 1.17878
1.4242 1.70321 2.01826 2.37187 2.76657 3.20495
3.68961 4.22322 4.80845 5.44803 6.14471 6.90127
7.72052 8.60531 9.55852 10.583 15.4534 20 30 40 50 60
70 80 90 100 ] ;
%N b = 6e6
%c mic = [2 e−5 5e−5 8.876 e−5 1.3 e−4 2e−4 3.788 e−4 6.2 e−4 8e−4
9.9101 e−4 1.3 e−3 2.2 e−3 3.79094 e−3 5e−3 6e−3 7e−3 8e−3 9.82101
e−3 1e−2 2e−2 3e−2 4.5557 e−2 6.25669 e−2 9.73273 e−2
0.143712 0.203657 0.279167 0.372308 0.485207
0.620045 0.779055 0.964523 1.17878 1.4242 1.70321
2.01826 2.37187 2.76657 3.20495 3.68961 4.22322
4.80845 5.44803 6.14471 6.90127 7.72052 8.60531
9.55852 10.583 15.4534 20 30 40 50 60 70 80 90 100 ] ;
%N b = 6e7
%c mic = [1 e−4 1.3 e−4 2e−4 3e−4 8e−4 1e−3 2e−3 3e−3 5e−3 7e−3 8e
70
−3 1e−2 1.3 e−2 2e−2 3e−2 4.5 e−2 6.25669 e−2 7.1 e−2 8e−2 9
e−2 0.1 0.12 0.143712 0.203657 0.279167 0.372308
0.485207 0.620045 0.779055 0.964523 1.17878 1.4242
1.70321 2.01826 2.37187 2.76657 3.20495 3.68961
4.22322 4.80845 5.44803 6.14471 6.90127 7.72052
8.60531 9.55852 10.583 15.4534 20 30 40 50 60 70 80 90
100 ] ;
%N b = 6e8
%c mic = [2 e−3 3e−3 5e−3 7e−3 8e−3 1e−2 1.5 e−2 2e−2 4e−2 5.2 e−2
6.1 e−2 7e−2 9.7 e−2 0.143712 0.203657 0.279167 0.372308
0.485207 0.55 0.620045 0.65 0.779055 0.964523 1.17878
1.4242 1.70321 2.01826 2.37187 2.76657 3.20495
3.68961 4.22322 4.80845 5.44803 6.1 6.9 7.72052
8.60531 9.55852 10.583 15.4534 20 30 40 50 60 70 80 90
100 ] ;
%N b = 6e9
%c mic = [ 2e−2 3e−2 4e−2 7e−2 0.143 0.2 0.27 0.37 0.48 0.6 0.7
1 1.3 1 .7 2 .1 2 .5 2 .7 3 3.9 5 .2 5 .8 6 .8 7 .6 8 9 10.583
15.4534 20 30 40 50 60 70 80 90 100 ] ;
%no demixing
%op t i ons = opt imse t ( ’MaxFunEvals ’ , 1 e4 , ’MaxIter ’ , 1e6 , ’TolX ’ , 1e
−12, ’TolFun ’ , 1e−12) ;
% l i p i d demixing
opt ions = opt imset ( ’ Display ’ , ’ i t e r ’ , ’ Algorithm ’ , ’ i n t e r i o r−point ’ ,
’ In i tBarr ie rParam ’ , 0 . 1 , ’ TolCon ’ , 1e−6, ’ MaxFunEvals ’ ,5 e3 , ’
MaxIter ’ , 1e6 , ’TolX ’ , 1e−10, ’ TolFun ’ , 1e−10) ;
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%x0 = [1 e−6; 1e−9]; %fo r a lph = 0.05 and Eps i lon = −14
x0 = [ 2 e−6; 6e−7; 0 . 5 ; 0 . 3 ] %for N b = 6e2−6e5
%x0 = [1 e−6; 6e−8; 0 . 5 ; 0 . 3 ] %6e6
%x0 = [7 e−7; 7e−8; 0 . 5 ; 0 . 3 ] ; %6e7
%x0 = [7 e−7; 8e−9; 0 . 5 ; 0 . 3 ] %6e8
%x0 = [8 e−11; 5e−12; 0 . 5 ; 0 . 3 ] %6e9
L = length ( c mic ) ;
for n = 1 :L
Cp = c mic (n) ∗(1 e−6)∗NA∗(1 e−27) ; % bu l k pep t i d e concen t ra t i on
(1/Angsˆ3)
%no l i p i d demixing
%[ x , f v a l ] = fminsearch (@( x ) l i p i d ( x ) , x0 , op t i ons ) %no l i p i d
demixing
% l i p i d demixing
[ x , f va l , e x i t f l a g ] = fmincon (@( x ) energy ( x ) , x0 , [ ( As−apef ) As 0
0 ] , [ 1 ] , [ ] , [ ] , [ 0 ; 0 ; 0 ; 0 ] , [SM;SM; 1 ; 1 ] , ’ c o n s t r a i n t ’ , opt i ons )
%x0 = [ x (1) , x (2) , x (3) , x (4) ] ;
%x0=[x (1) , x (2) ] ;
P L(n , 1 ) = c mic (n) ;
P L(n , 2 ) = x (1) ∗ a l
end
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dlmwrite ( ’ P L . txt ’ , P L , ’ d e l i m i t e r ’ , ’\ t ’ , ’ p r e c i s i o n ’ , 6)
X = c mic ;
plot (X, P L ( : , 2 ) )
ylabel ( ’ P L ’ , ’ f o n t s i z e ’ ,12 , ’ f ontwe ight ’ , ’ b ’ )
xlabel ( ’ cp ’ , ’ f o n t s i z e ’ ,12 , ’ f ontwe ight ’ , ’ b ’ )
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C.1 The function to calculate the free energy of the
peptide-membrane system
function G = l i p i d ( x )
global Q a l alph ap Cp apef
Eps = 8.85 e−12;
T = 300 ;
Kb = 1.38∗1 e−23;
Dw = 80 ;
NA = 6.023∗1 e +23;
e = 1 .6 e−19;
lb = e ˆ2∗1 e +10/(4∗pi∗Eps∗Dw∗Kb∗T) ;
kapain = 10 ; %Angstrom
C 0 = 1/( kapain ˆ2 ∗8∗pi∗ lb ) ;
Ac = 6e8 ; %Bacterium sur f a ce area in aangstromˆ2
Ah = 1e10 ; %Host c e l l s u r f a c e area in aangstromˆ2
ap = 162 ; %246 , 314
apef = ap ; %symmetric b ind ing
%ape f = ap/2 f o r asymmetric b ind ing
a l = 71 ; %74 , 65
alph = 0 . 3 ; %0.05
Q = 6 ;
%Magainin
%vp = 2512; %V=314∗8 Aˆ3
%Me l i t t i n
vp = 33ˆ3 ;
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V = 1e27 ; % t o t a l volume in Angstromˆ3
Ct = 6e4∗1e−24; %c e l l d en s i t y ( c e l l s /(Aˆ3)
A = 2∗Ac ; %symmetric b ind ing
%A = Ac %Asymmetric b ind ing
KA = 0 . 5 7 8 ; %KbT/Aˆ2
SM = 1/ap ;
%FE = ( x (1) ∗WSIND( x )+x (2) ∗WSSND( x ) ) ; %wi thout l i p i d demixing
FE = x (1) ∗WSI( x (1 ) , x (2 ) , x (3 ) )+x (2) ∗WSS( x (1 ) , x (2 ) , x (4 ) ) ; %with
l i p i d demixing
ME = (1/2) ∗KA∗(x (1 ) ∗ apef ) ˆ2 ;
% with pep t i d e r e s e r v o i r
%EntG = x (1) ∗ l o g ( x (1) ∗ap/( cp∗vp ) ) + (SM−x (1)−x (2) )∗ l o g (1−(( x (1)+x
(2) )/SM) ) + x (2) ∗ l o g ( x (2) ∗ap/( cp∗vp ) ) ;
% wi thout p ep t i d e r e s e r v o i r
Ent b = x (1) ∗ log ( x (1 ) ∗ap ) + (SM−x (1 )−x (2 ) )∗ log (1−((x (1 )+x (2) ) /SM)
) + x (2) ∗ log ( x (2 ) ∗ap ) ;
Ent f = (1/(V∗Ct∗A) ) ∗( V∗(Cp−Ct∗A∗(x (1 )+x (2) ) )∗ log ( (Cp−Ct∗A∗(x (1 )
+x (2) ) )∗vp ) − (Cp∗V−Ct∗V∗A∗(x (1 )+x (2) ) ) − (Cp∗V∗ log (Cp∗vp )−Cp∗
V) ) ;
;
EntC = Ent b + Ent f ;
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%F re f e rence
S 0 = −alph / a l ;
Ps = 2∗asinh (2∗pi∗S 0∗ lb ∗kapain ) ;
Fm = S 0∗Ps − ( cosh ( Ps /2)−1)/( kapain∗pi∗ lb ) ;
Entm = ( alph∗ log ( alph )+(1−alph )∗ log(1−alph ) ) / a l ;
%magainin
%E co i l = [0 .1755 1.1663 2.7428 4.7889 7.2350
10.0339 13.1510 16.5596 20.2384 24 . 1697 ] ;
% me l i t t i n
E c o i l = [ 0 . 0 3 5 2 0 .7136 1 .8818 3 .4487 5 .3573
7 .5683 10.0524 12.7872 15.7544 1 8 . 9 3 9 2 ] ;
Fp = ( x (1)+x (2) )∗E c o i l (Q) ;
F r e f = Fp + Fm + Entm ;
G = FE + ME + EntC − F r e f ;
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C.2 The function to calculate the WSC free energy
function FWSI = WSI(J , S ,K) %membrane−i n s e r t e d p ep t i d e s
global Q alph a l ape f ap
Eps = 8.85 e−12;
T = 300 ;
Kb = 1.38∗1 e−23;
Dw = 80 ;
NA = 6.023∗1 e +23;
e = 1 .6 e−19;
lb = e ˆ2∗1 e +10/(4∗pi∗Eps∗Dw∗Kb∗T) ;
kapain = 10 ; %Angstrom
C 0 = 1/( kapain ˆ2 ∗8∗pi∗ lb ) ;
rp = sqrt ( ap/pi ) ;
x (1 ) = J ;
x (2 ) = S ;
a l f p = K;
Aws = (1+x (1) ∗ apef ) /( x (1 )+x (2) ) ;
lambda = a l /(2∗pi∗ lb ∗alph ) ;
As = pi ∗( rp+lambda ) ˆ2 ;
%Zone1
Sigp = Q/As − a l f p ∗(As−ap ) /( a l ∗As) ;
ps ip = 2∗asinh (2∗pi∗Sigp∗ lb ∗kapain ) ;
F1 = Sigp∗ ps ip − ( cosh ( ps ip /2)−1)/( kapain∗pi∗ lb ) ;
Ent1 = ( a l f p ∗ log ( a l f p )+(1−a l f p )∗ log(1− a l f p ) ) / a l ;
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%zone2
a l f = ( alph ∗(Aws−ap )−a l f p ∗(As−ap ) ) /(Aws−As) ;
s i g = −a l f / a l ;
p s i = 2∗asinh (2∗pi∗ s i g ∗ lb ∗kapain ) ;
F2 = s i g ∗ p s i − ( cosh ( p s i /2)−1)/( kapain∗pi∗ lb ) ;
Ent2 = ( a l f ∗ log ( a l f )+(1− a l f )∗ log(1− a l f ) ) / a l ;
eh = −14; %hydrophobic energy
FWSI = As∗F1 + (Aws−As)∗F2 + Ent1 ∗(As−ap ) + Ent2 ∗(Aws−As) + eh ;
function FWSS = WSS(D,B,N) %sur face−adsorbed p ep t i d e s
global Q As alph a l ape f ap
Eps = 8.85 e−12;
T = 300 ;
Kb = 1.38∗1 e−23;
Dw = 80 ;
NA = 6.023∗1 e +23;
e = 1 .6 e−19;
lb = e ˆ2∗1 e +10/(4∗pi∗Eps∗Dw∗Kb∗T) ;
kapain = 10 ; %Angstrom
C 0 = 1/( kapain ˆ2 ∗8∗pi∗ lb ) ;
rp = sqrt ( ap/pi ) ;
x (1 ) = D;
x (2 ) = B;
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a l f p = N;
Aws = (1+x (1) ∗ apef ) /( x (1 )+x (2) ) ;
lambda = a l /(2∗pi∗ lb ∗alph ) ;
As = pi ∗( rp+lambda ) ˆ2 ;
%Zone1
Sigp = Q/As − a l f p / a l ;
ps ip = 2∗asinh (2∗pi∗Sigp∗ lb ∗kapain ) ;
F1 = Sigp∗ ps ip − ( cosh ( ps ip /2)−1)/( kapain∗pi∗ lb ) ;
Ent1 = ( a l f p ∗ log ( a l f p )+(1−a l f p )∗ log(1− a l f p ) ) / a l ;
%zone2
a l f = ( alph∗Aws−a l f p ∗As) /(Aws−As) ;
s i g = −a l f / a l ;
p s i = 2∗asinh (2∗pi∗ s i g ∗ lb ∗kapain ) ;
F2 = s i g ∗ p s i − ( cosh ( p s i /2)−1)/( kapain∗pi∗ lb ) ;
Ent2 = ( a l f ∗ log ( a l f )+(1− a l f )∗ log(1− a l f ) ) / a l ;
FWSS = As∗F1 + (Aws−As)∗F2 + Ent1∗As + Ent2 ∗(Aws−As) ;
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